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Preface
Accurate epidemiologic information is essential for making
good decisions about developing, implementing, monitoring,
and evaluating health policies. To ensure the quality of infor-
mation gathered, CDC created the Epidemic Intelligence Ser-
vice (EIS) in 1951. Since then, approximately 32 countries
have developed field epidemiology and allied training pro-
grams (FETPs) based on the EIS model, all sharing a com-
mon principle of training through service.
In the 1990s, work began to create a unified global network,
and in 1999, the Training Programs in Epidemiology and Pub-
lic Health Interventions Network (TEPHINET) was formed.
TEPHINET is dedicated to strengthening international public
health capacity by enhancing competencies in applied epide-
miology and public health practice. Nearly all of the 32 FETPs
in the network began as partnerships between national minis-
tries of health, the Division of Epidemiology and Surveillance
Capacity Development (formerly the Division of International
Health) of CDC’s Coordinating Office for Global Health, and
the World Health Organization (WHO).
This supplement to the MMWR highlights the work of epi-
demiologists who have graduated from TEPHINET member
programs. The articles were developed from abstracts presented
in Beijing, China, at the Third Global Scientific Conference
of TEPHINET during November 8–12, 2004. Major fund-
ing for the conference was provided by the Bill and Melinda
Gates Foundation. Approximately 230 field epidemiologists
from 40 countries participated to share best practices and new
ideas in field epidemiology, surveillance, response, and train-
ing. The reports selected for publication in this supplement
focus on the contributions TEPHINET members and their
trainees and graduates have made in surveillance of and
response to emerging infectious diseases. They reflect the broad
impact of the training programs.
Field epidemiology trainees studied major emerging prob-
lems of global concern (e.g., avian influenza in Thailand) and
common outbreaks (e.g., salmonellosis and varicella in China).
Trainees applied their skills to investigate occupational inju-
ries in Zimbabwe, evaluate a tuberculosis control program in
Kazakhstan, and adapt statistical methodologies used for
industrial quality control to estimate vaccination coverage in
India. The Canadian contribution highlights the application
of epidemiologic methods to improve product safety for
cochlear implants, and two papers discuss how to use case-
control methodology to identify risk factors for brucellosis in
Kyrgyzstan and neonatal tetanus in Uganda.
A key characteristic of TEPHINET members’ training-through-
service programs is their location in national ministries of health.
This enables TEPHINET to offer global and regional organiza-
tions access to public health professionals who conduct surveil-
lance and respond to health threats. Network members serve more
than half of the world’s population, including the United States
(Figure). Just as EIS provides critical personnel for the U.S. pub-
lic health system, FETPs in TEPHINET provide essential staff
to their own countries and regions.
As founding members of TEPHINET, WHO and CDC
maintain close partnerships with the organization. With
assistance from WHO and CDC, TEPHINET is piloting a
continuing quality improvement process that is expected to
lead to steady improvement in the quality of science and level
of service that FETPs provide. In addition to its training and
capacity building role, TEPHINET is a member of WHO’s
Global Outbreak Alert and Response Network (1) and pro-
vides experts for WHO investigative teams.
The new International Health Regulations require each
nation to have competent public health personnel for epi-
demic surveillance and response (2). TEPHINET and its mem-
ber programs will be major participants in achieving this goal.
TEPHINET, WHO, and CDC are currently working together
to create new FETPs in seven countries or regions worldwide.
Much of the work of FETP staff, trainees, and graduates is
accomplished as they fulfill duties in their national public health
systems and has not been published. Because of the value of
this applied science, we are pleased at this opportunity to share
a selection of the many excellent studies produced by
TEPHINET member programs and their graduates.
Stephen B. Blount, MD Roberto Flores, MD
Associate Director for Global Health and Chairman, TEPHINET
Director, Coordinating Office
for Global Health, CDC
FETPs
FIGURE. Field epidemiology training and allied programs
(FETPs), 2005
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Abstract
Introduction: Beginning in late 2003, a substantial outbreak of influenza A (H5N1) virus spread among poultry in Thailand. On
January 23, 2004, the Ministry of Public Health (MPH) detected the first confirmed human case of H5N1 infection in humans.
Methods: During February–November 2004, the MPH’s Bureau of Epidemiology and provincial health offices worked
together to investigate the H5N1 outbreak in humans. Two studies were conducted: a descriptive study to describe clinical
manifestations and epidemiologic characteristic of the cases and a matched case-control study to determine risk factors for
persons who might subsequently become ill with H5N1.
Results: A total of 16 patients with confirmed H5N1 were identified for the case-control study. Fever and respiratory symp-
toms predominated. Leucopenia and thrombocytopenia were present respectively in nine (100%) and four (44%) persons
aged <15 years. Direct touching of unexpectedly dead poultry was the most significant risk factor (odds ratio = 29.0; 95%
confidence interval = 2.7–308.2). Overall mortality was 75%; mortality for persons aged <15 years was 90%, compared
with 57% for persons aged >15 years.
Conclusion: Avian influenza was more severe in children, who should avoid handling dead poultry during epizootics. Early
avian influenza in children resembled the more common dengue fever, but presence of cough and absence of hemoconcentration
distinguished avian influenza, which often progressed rapidly to acute respiratory distress syndrome, requiring intensive care.
Introduction
In 1997, the first outbreak of avian influenza A (H5N1) in
humans was reported in Hong Kong, and exposure to infected
poultry was identified as the probable route of transmission
(1–3). Since late 2003, this highly pathogenic virus has caused
disease outbreaks in poultry in at least eight East Asian coun-
tries, and fatalities among humans have been attributed to the
same virus in Cambodia, China, Indonesia, Thailand, and
Vietnam (4,5). During December 2003–October 2004, a
total of 17 cases of respiratory disease caused by H5N1
viruses were reported in Thailand; these cases coincided in
time and place with the epizootic disease in poultry. Millions
of persons in Thailand raise backyard chickens near their
houses, which has increased concern about the potential for a
substantial H5N1 outbreak in humans.
Methods
During February–November 2004, the Bureau of Epide-
miology (BoE) of the Ministry of Public Health (MPH) and
provincial health offices worked together to investigate the
H5N1 outbreak in humans. Two studies were conducted: a
descriptive study to describe clinical manifestations and epi-
demiologic characteristic of the cases and a matched case-
control study to determine risk factors for persons who might
subsequently become ill with H5N1.
Descriptive Study
Case Definition
Under Thailand’s nationwide avian influenza surveillance
system, which BoE initiated in December 2003, any patient
admitted to a health-care facility with pneumonia or influenza-
like illness who has a history of exposure to poultry is reported
to BoE. For this study, a case was defined as H5N1 illness
occurring in a person who had received a diagnosis of pneu-
monia or influenza-like illness and who had either a positive
viral culture for H5N1 virus or confirmation of H5 strain by
real-time reverse transcription-polymerase chain reaction
(RT-PCR) (6,7).
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Laboratory Testing
Each patient was evaluated for H5N1 infection status at
the time of hospital admission. Nasopharyngeal aspirates or
nasopharyngeal swabs were collected and submitted to the
Thai National Institute of Health or to Siriraj Hospital at
Mahidol University for laboratory testing.
Data Collection and Analysis
A standard form was used to collect information concern-
ing clinical manifestations as recorded on medical records.
Clinical manifestations and clinical progressions were analyzed
using Epi Info 2002 version 2 (CDC, Atlanta, Georgia) and
Excel (Microsoft, Redmond, Washington).
Analytic Study
Study Design and Sampling
A matched case-control study was conducted during the
outbreak using the same case definition as the descriptive study.
Population registers in the primary health-care unit of each
village were used as the control sampling frame. Controls were
selected matching village and age ±1 year to each patient and
then randomly selecting four controls for each patient. For
one patient who was thought to have been infected through
human-to-human transmission, four controls were selected
from among health-care workers in the hospital to which the
patient was admitted. A control was defined as any person
who had no fever (i.e., temperature >100.4°F [>38.0°C])
<7 days before or after the onset of illness of the matched
case-patient. With respect to exposure, unexpectedly dead
poultry was defined as death of >10% of
all poultry in a farm or house within
1 day or >40% within 3 days.
Data Collection and Analysis
Interviews were conducted by physi-
cians in BoE’s Field Epidemiology Train-
ing Program. For persons who had died
or were aged <12 years, adult proxies were
interviewed. A standard questionnaire
was used to collect information regard-
ing demographic characteristics, under-
lying diseases, exposure to other persons
with suspected avian influenza, and
activities related to poultry in the week
before onset of illness in the matched
case-patient. In the univariate matched
analyses, the matched odds ratio (OR)
and 95% confidence interval (CI) were
calculated for each exposure using Epi
Info 2002 version 2. The Mantel-Haenszel summary chi square
test was used for the matched data.
Results
The outbreak in humans occurred in two episodes:
January–March and August–October 2004 (Figure 1). Of 17
cases reported from the avian influenza surveillance system,
one was excluded because of incomplete laboratory results;
16 patients with confirmed H5N1 infection were included in
the study.
Patients lived in 11 provinces, primarily in central Thai-
land. Nine were male and seven female. Patients varied by age
(range: 2–58 years; median: 13 years). Of the 16 patients
included in the study, nine (56%) were aged <15 years. Over-
all mortality was 75%; mortality for persons aged <15 years
was 90%, compared with 57% for persons aged >15 years
(OR = 6.4; CI = 0.4–204.2).
The incubation period varied (range: 2–8 days; median:
3 days). All patients had fever. Respiratory symptoms pre-
dominated, including cough (12 patients [75%]), sputum
(12 [75%]), dyspnea (11 [69%]), and rhinorrhea (seven
[44%]); four (25%) patients had gastrointestinal symptoms
(Figure 2). All nine patients aged <15 years had leucopenia
(white blood cell count: <5,000 cells/mm3; normal range:
5,000–10,000 cells/mm3), and four (44%) also had thromb-
ocytopenia (platelet count: <100,000 cells/mm3; normal range:
100,000–400,000 cells/mm3). The median hematocrit in per-
sons aged <15 years was 39% (range: 30%–41%). Clinical
progressions demonstrated rapid progressive pneumonia and
FIGURE 1. Number* of persons with confirmed cases of avian influenza, by date
of onset — Thailand, December 2003–October 2004







1 15 29 12 26 9 23 8 22 5 19 3 17 31 14 28 12 26 9 23 9 20 4 18
Dec
2003






























Vol. 55 / Supplement MMWR 5
acute respiratory distress syndrome (ARDS) in all persons who
died (Table 1). In the matched case-control study, case-
patients and controls were similar with respect to the majority
of variables (Table 2).
From the univariate matched analyses, direct touching of
unexpectedly dead poultry yielded the highest odds ratio
(OR = 29.0; 95% CI = 2.7–308.2). Having poultry die in or
near the house or performing activities related to poultry was
significantly associated with H5N1 disease (Table 3). No sta-
tistically significant difference was identified among patients
reporting contact with persons with a suspected case of
human avian influenza (Table 3).
Discussion
The H5N1 outbreak in humans in Thailand during
January–March and August–October 2004 affected prima-
rily children. Overall mortality was high (75%). During the
same period, mortality among persons with human cases in
Vietnam was also high (80%) (8). These data suggest that the
disease has become more severe than that reported in Hong
Kong in 1997, in which mortality was only 33% (2). How-
ever, availability of early aggressive treatment in Hong Kong
in 1997 or mutation of the virus might explain this differ-
ence. During December 16, 2004–December 8, 2005, global
mortality among persons with human cases was 29% (5).
Basic laboratory profiles in children indicated leucopenia
and thrombocytopenia. These laboratory results in children
led attending physicians initially to suspect dengue fever in
the differential diagnosis. However, certain differences helped
clinicians differentiate between H5N1 infection and dengue
fever. In H5N1 cases, respiratory symptoms typically predomi-
nate, and case-patients did not exhibit hemoconcentration (7).
The rapid progressive pneumonia and ARDS required physi-
cians in the epizootic areas to be aware of the possibility of
H5N1 infection before patients’ illness progressed to severe
pneumonia.
In the matched analyses, H5N1 disease was associated with
recent exposure to sick or unexpectedly dead poultry, particu-
larly direct touching of unexpectedly dead poultry. Only one
patient was reported to have been exposed in a live poultry
market. In contrast, the 1997 Hong Kong outbreak was
related to exposure to live poultry market (2,9). A family cluster
was recognized in Thailand in September 2004, probably as a
result of person-to-person transmission during unprotected
exposure to a critically ill index patient (10). Vietnam also
reported probable human-to-human transmission in Febru-
ary 2004 (11). Moreover, in Hong Kong in 1997, a study
demonstrated H5N1 infection among health-care workers
exposed to a patient with H5N1 infection (12). The risk for
person-to-person transmission of H5N1 virus might increase,
either through viral mutation or reassortment. This empha-
sizes the need for strong surveillance, early detection, and
intensive measures to protect unexpected person-to-person
transmission.
The findings in this report are subject to at least five limita-
tions. First, because a substantial number of patients had died,
case interviews were conducted more frequently by proxy than
FIGURE 2. Clinical manifestations of influenza A (H5N1)
patients from onset of illness to hospital admission, by
symptom and age — Thailand, December 2003–October 2004
* Body temperature of >100.4°F (>38°C).
† White blood cell.
















TABLE 1. Clinical progressions of influenza A (H5N1) patients,
by symptoms and days after exposure to birds — Thailand, 2004
No. of days
Symptoms Median Range
Onset of illness with fever,* cough,
or rhinorrhea (n = 16) 4 2–8
Pneumonia (n = 13) 9 6–12
ARDS† (n = 12) 10 8–18
* Defined as body temperature >100.4°F (>38°C).
†Acute respiratory distress syndrome.
TABLE 2. Number and percentage of influenza A (H5N1)
case-control study participants, by selected characteristics —
Thailand, 2004
Cases Controls
(n = 16) (n = 64)
Characteristic No.     (%) No.     (%)
Median no. of family members 4 5
Median age (yrs) 14 14
Sex
Male 9 (56) 31 (48)
Female 7 (44) 33 (52)
Smoking
Yes 2 (13) 9 (14)
No 14 (87) 55 (86)
Chronic medical condition
Yes 2 (13) 10 (16)
No 14 (87) 54 (84)
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were control interviews. Second, recall bias might have
occurred as a result of the public’s high level of alarm.
Third, exposure to poultry was part of the surveillance
requirement, and results might have been biased toward
these exposures. Fourth, because dengue serology was not
documented for patients, combined dengue and H5N1 in-
fections cannot be ruled out. Finally, matching one case
patient with health-care workers rather than community con-
trols might have introduced bias.
During and after performance of this study, multiple rec-
ommendations were provided to health-care workers. In areas
that have unexpectedly dead poultry, clinicians should have a
high index of suspicion for avian influenza in patients with acute
respiratory illness and quickly distinguish between H5N1 and
other viral infections (e.g., dengue fever) that have similar labo-
ratory profiles in children. Persons (especially children) should
avoid direct contact with unexpectedly sick or dead poultry
and not store products from unexpectedly dead poultry in the
home. When contact is unavoidable, persons should use per-
sonal protective equipment and wash their hands frequently.
Long-term public health surveillance and control measures are
needed to monitor for person-to-person transmission and the
emergence of a potentially pandemic H5N1 influenza virus.
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Abstract
Introduction: During 2001–2002, a total of 97 occupational injuries occurred among workers in the cleansing section of the
Bulawayo, Zimbabwe, City Council’s Health Services Department. This report describes a study that was conducted to
describe the nature of these injuries and determine the associated risk factors.
Methods: A retrospective, descriptive cross-sectional survey was conducted concerning occupational injuries incurred by workers in
the cleansing section during 2001–2002. A total of 153 workers who had been in the section as of January 1, 2001, and 23
senior managers and section supervisors were interviewed, the occupational injury register was reviewed, and a walk-through
survey was conducted to estimate risk factors.
Results: The occupational injury register indicated that during the study period, 62 workers sustained 67 injuries, including
one that was fatal. Of these 67 injuries, 27 (40%) involved workers who sustained cuts inside a box-type refuse removal truck,
and 11 (16%) involved workers who had sprained ankles and wrists as a result of improper lifting. Workers aged 18–25 years
were more likely to incur an injury than workers aged >25 years. Working as a bin loader and not having received preemployment
training were associated with injuries. None of the bin loaders had received preemployment training. Hazards identified
during the walk-through survey included use of small jacks in workshops, contact with biologic and chemical materials on
trucks and landfill sites, and poor use of protective clothing. Supervisors cited worker negligence as the main cause of injury,
whereas 72 (84%) workers cited lack of adequate protective clothing as a source of injury, and eleven (7%) workers cited use
of inappropriate equipment.
Conclusion: On the basis of the modifiable risk factors for injury identified in this study, the Bulawayo City Council drafted
a new health and safety training manual. New recruits now receive training before starting work on refuse collection trucks.
Introduction
Occupational injuries continue to be a serious but poorly
documented problem in both developed and developing coun-
tries. The International Labour Organisation estimates that
worldwide, workers sustain 250 million unintentional occu-
pational injuries and an additional 330,000 fatalities annu-
ally (1). Reducing the number of injuries is one of Zimbabwe’s
top 10 health priorities (2). The highest numbers of occupa-
tional injuries in Zimbabwe occur in the construction, min-
ing, and manufacturing industries. Service industries,
including local government authorities, accounted for 1,707
(12%) of the 13,854 occupational injuries reported during
2000 (3).
The Bulawayo City Council Health Services Department
(HSD) monitors the city’s public health standards, including
refuse disposal services provided by the cleansing section.
During 2001–2002, a total of 97 injuries occurred among
HSD workers, one of which was fatal (4). Of these 97 inju-
ries, 67 (73%) occurred in the cleansing section, including
the one fatality. After the City Council and employees
expressed concern regarding the high incidence of occupa-
tional injuries in the section, a study was conducted to
describe the nature of injuries and estimate the associated risk
factors.
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TABLE 1. Number and percentage of occupational injuries among workers in the cleansing section of the Bulawayo City Council
Health Services Department, by injury type and cause — Bulawayo, Zimbabwe, 2001–2002
Type Risk factor No. (%*)
Cut on hand, finger, thumb, or foot Broken glass or sharp objects 27 (40)
Sprained ankle or wrist Improper lifting or throwing technique, or running and disembarking from vehicle 11 (16)
Eye injury Dust, liquid, chemicals, or smoke 8 (12)
Shoulder injury Contact collision 8 (12)
Knee injury Contact collision, slip, or fall 5 (8)
Laceration of leg or finger Dog or scorpion bite 4 (6)
Sharp back pain Excessive effort in lifting 3 (5)
Trunk injury Run over by truck 1 (2)
Total 67
* Total might exceed 100% because of rounding.
Methods
Records of injuries that occurred during January 2001–
December 2002 were reviewed, and a cross-sectional survey
was conducted in the HSD cleansing section during June 2003
to determine demographic and personal risk factors associ-
ated with injuries. Of 188 eligible general workers, 153 (84%)
were interviewed along with 23 senior managers and section
supervisors. Of 62 workers who had an injury during the study
period, 51 (82%) were interviewed. All participants were
informed that the purpose of the study was to find risk factors
and make recommendations to improve the work environ-
ment. Persons interviewed gave informed written consent. A
walk-through survey of public restrooms, mechanical work-
shops, a landfill site, and the suburban refuse collection pro-
cess also was conducted. A checklist adapted from CDC’s
National Institute of Occupational Health (5) and a form
(Occupational Health and Safety Form OHS IAF 2003) cre-
ated by the National Social Security Authority (NSSA) of Zim-
babwe were used to identify environmental risk factors. Data
were analyzed using Epi Info 2002 (CDC, Atlanta, Georgia).
Univariate analysis, frequencies, prevalence odds ratios, and
p values at 95% confidence intervals (CIs) were reported. A
result with a value of p<0.05 was considered statistically sig-
nificant.
Results
Results from Register of Occupational
Injuries
The register of occupational injuries indicated that 62 work-
ers were injured at least once during the study period; of 67
injuries that occurred, one was fatal (Table 1). The death
occurred when a bin loader slipped and was run over by the
back wheels of a refuse truck. Injuries occurred throughout
the week with no association to day of week or hour of day.
Of the 51 injuries for which interviews could be conducted,
13 (25%) injuries were classified as major because they
resulted in permanent scars and in loss of >3 working days, and
38 (74%) were minor. Only three of the 13 workers with major
injuries received any compensation, and the amount they
received was negligible (average: <$1 U.S. per month). Data
regarding whether the family of the deceased worker was
receiving compensation were not available. HSD management
is responsible for the initial assessment and forwarding of nec-
essary documentation and referral of workers to NSSA for pay-
ment of compensation. Neither workers nor management
appeared to understand the compensation system.
Personal Risk Factors
The section workforce included 147 (96%) men and six
(4%) women. Risk factors associated with suffering an injury
were age 25 years (odds ratio [OR] = 3.2; CI = 1.6–9.2), work-
ing as a bin loader (OR = 3.6; CI = 1.1–4.8), not having
received preemployment training (OR = 3.1; CI = 1.3–7.5),
and subsequently rating the job as difficult to perform (POR =
2.9; CI = 1.1–7.7) (Table 2). Potential environmental hazards
cited by workers included inappropriate equipment (cited by
30 [22%] workers), dust (22 [14%]), biologic material (20
[13%]), sharp objects (17 [11%]), and chemicals (15 [10%]).
A total of 72 (84%) workers said provision of adequate per-
sonal protective equipment (PPE) would help in the preven-
tion of injury. Another 11 (7%) workers said that provision of
appropriate equipment could help in injury prevention. A total
of 29 (20%) workers could not name any potential hazards.
Environmental Hazards
A walk-through inspection revealed human waste on
restroom floors. Workers were at risk for splashes into exposed
eye and mouthparts because they did not wear goggles or face
masks during cleaning of restrooms. Workshops were over-
crowded, with dirty vehicles under repair. All workers wore
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overalls, but none wore gloves to avoid contamination from
materials left in refuse trucks. Mechanics used small jacks to
lift trucks and were at risk for injury as a result of heavy equip-
ment falling.
Two types of trucks were used for refuse collection: an old
box-type truck and a modern hydraulic-compactor refuse-
collection truck (Figure). The compactor has side steps on
which bin loaders stand, and workers do not come into con-
tact with rubbish. However, workers loading the box-type truck
must lift bins above their shoulder level, and workers inside
the truck come into direct contact with hazardous materials
and are at risk for sustaining cuts to their legs, feet, or fingers
while spreading out rubbish. Use of PPE was limited. Of 62
bin loaders observed during the bin-collection pro-
cess, 27 (44%) had worn-out footwear, and 22 (32%)
had overalls in bad condition. Only 17 (28%) wore
respirator masks, and none wore head protection,
although both are necessary to prevent injury. Work-
ers are issued two pairs of overalls and a pair of boots
twice annually. Heavy-duty gloves are issued every 2
weeks, and face masks are issued on demand.
Poor disposal habits of medical practitioners
resulted in needles and bandages being present in
refuse collection trucks, and uncovered biologic and
chemical materials were observed at the landfill. Scav-
engers were observed at the dump site, which could
cause unintentional injuries. Another hazard was that
dust and noise were generated during the compact-
ing process.
The presence of the hazards identified in the walk-
through survey was confirmed by 23 senior managers
and supervisors, who attributed injuries to the need
for manual labor and to workers being careless and
failing to follow the departmental safety protocol
However, no written documented safety protocol was
identified. Supervisors also said that workers sold
their allocation of work clothes.
Section supervisors who were directly
responsible for the workers said that not much could
be done in the section because of poor communica-
tion in the department and that directors did not
welcome requests, especially those involving capital
expenditure. Supervisors said risk could be reduced
by providing modern equipment and adequate PPE
and by reducing the workload.
Discussion
Workers aged 18–25 years were more likely to suf-
fer an injury than workers aged >25 years. Among
workers in all industries, frequency of injuries has been dem-
onstrated to decline with age (6). Younger workers might be
more prone to injury because of their lack of experience and
an inclination to take unnecessary risk.
Bin loaders were more likely to be injured than toilet or
street cleaners. The absence of training at the beginning of
employment was also identified as a risk factor. Bin loading
involves handling of heavy loads and working with moving
trucks. Workers should be trained in good lifting techniques
and how to avoid vehicular accidents. Incidence of back
injuries has been reduced substantially after training in proper
lifting techniques (7).
TABLE 2. Number and percentage of occupational injuries among
workers in the cleansing section of the Bulawayo City Council Health
Services Department, by selected characteristics — Bulawayo,
Zimbabwe, 2001–2002
Injured Not injured
Characteristic No. (%) No. (%) OR* (95% CI†)
Age group (yrs)§
18–25 13 (25) 9 (9) 3.2 (1.2–9.2)
26–64 38 (75) 93 (91)
Marital status
Married 41 (80) 85 (83) 0.8 (0.3–1.5)
Not married 10 (20) 16 (17)
Medical condition
Yes 6 (12) 8 (8) 1.8 (0.6–5.7)
No 45 (88) 94 (92)
Education level
Secondary or above 33 (65) 46 (45) 2.2 (1.1–4.8)
Primary or none 18 (35) 56 (55)
Work position
Bin loader 43 (84) 54 (53) 3.6 (1.6–8.1)
Other 8 (16) 48 (47)
Length in service (yrs)
<3 14 (27) 20 (20) 1.6 (0.7–3.4)
4–35 37 (73) 82 (80)
Preemployment training
No 41 (80) 58 (57) 3.1 (1.3–7.5)
Yes 10 (20) 44 (43)
Health and safety training
No 46 (90) 91 (91) 1.1 (0.3–3.9)
Yes 5 (10) 11 (11)
Job rating¶
Difficult (3–5) 45 (88) 73 (72) 2.9 (1.1–7.7)
Easy (1–2) 6 (12) 29 (28)
Knowledge of hazards
No 2 (4) 27 (26) 0.1 (0.02–0.5)




§Age groups were classified on the basis of surveys, which indicated statistically
significant patterns in the occurrence of injuries in three age groups (18–25, 26–55,
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FIGURE. Box-type (top) and hydraulic compactor (bottom)
refuse-collection trucks — Bulawayo, Zimbabwe, 2003
SOURCE: Bulawayo City Council, Bulawayo, Zimbabwe, 2003
The findings in this report are subject to at least two limita-
tions. First, a walk-through inspection might not have identi-
fied all hazards. Second, interview data were missing for 18%
of persons with injuries and for 19% of persons without inju-
ries. If these persons represent different distribution of risk
factors than persons included in the study, ORs might be
underestimated or overestimated.
Conclusion
This report indicates the importance of keeping accurate
records of the causes of injury so appropriate interventions
can be made to prevent future injuries. Injuries that occurred
in the cleansing section during 2001–2002 could have been
reduced or, in some instances, avoided by implementing ap-
propriate interventions. As a result of these findings, the
Bulawayo City Council has compiled a health and safety
manual for use in the department. New recruits in the bin
loading section are now trained before they start work. HSD
was advised to provide proper jacks in its mechanical work-
shops and to devise a plan to gradually phase out the old refuse
removal trucks. To reduce the risk for injury, small jacks and
old box trucks should be replaced with modern
hydraulic trucks, and proper use should be made of PPE.
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Abstract
Introduction: In Kazakhstan, during 1995–2002, the annual notification rate per 100,000 population for new cases of
tuberculosis (TB) increased from 67.1 to 165.1. Beginning in 1998, public health authorities have used the national case
management strategy (DOTS) promulgated by the World Health Organization (WHO) to control TB. Intended goals of
DOTS include achieving a cure rate of >85% for persons with newly detected pulmonary TB sputum-smear–positive (PTB+)
cases and having PTB+ represent >65% of all PTB cases among adults. Surveillance data collected during 2000–2002 were
analyzed to evaluate progress toward achieving these goals and identify factors associated with specific treatment outcomes.
Methods: Surveillance data included the following nonidentifiable information on persons with newly reported cases of PTB:
dates of disease onset and treatment initiation; methods of diagnosis; treatment outcomes; HIV status; and selected demo-
graphic, socioeconomic, and behavioral characteristics. Cure rates and proportions of PTB+ cases were calculated on the basis
of the TB case definition and treatment outcome classification format outlined in DOTS guidelines issued by WHO.
Denominator data to calculate rates were obtained from the National Census Office of Kazakhstan. Logistic regression was
employed to investigate factors associated with treatment outcomes using Epi Info version 3.2.
Results: During 2000–2002, a total of 65,011 new cases of PTB were detected in Kazakhstan. The average annual country-
wide notification rate per 100,000 population was 146.0; provincial notification rates varied (range: 65.1–274.0). The
countrywide cure rate for newly detected PTB+ was 72.2%; provincial rates varied (range: 65%–81%). Of 59,905 cases of
PTB among adults during 2000–2002, a total of 26,804 (44.7%) were PTB+. Unfavorable treatment outcome of new
PTB+ cases was associated with alcohol abuse, homelessness, and previous incarceration.
Conclusion: The cure rate for new PTB+ cases and the proportion of cases of PTB+ among all adults with PTB were below
targeted goals. This might, in part, be explained by the 1998 adoption of DOTS. Improving program indicators requires
evaluation of detection efforts, laboratory diagnostic capabilities, and adherence to treatment regimens, especially in provinces
in which rates are high and among persons at high risk for unfavorable treatment outcomes.
Introduction
In 1993, the World Health Organization (WHO) adopted
a national case management strategy (DOTS) to reduce the
increasing global burden of tuberculosis (TB), especially in
developing countries (1). The five elements of the DOTS strat-
egy are sustainable government commitment, quality assur-
ance of sputum microscopy, standardized short-course
treatment (including direct observation of therapy), regular
supply of drugs, and establishment of reporting and
recording systems (2,3). The goal of DOTS is to reduce TB
morbidity and mortality and the chance of Mycobacterium
tuberculosis developing resistance to primary treatment drugs
(4). Target goals of TB control adopted in 1991 by the World
Health Assembly (3) include >70% detection rate of the esti-
mated incidence of sputum-smear–positive pulmonary TB
(PTB+) and >85% cure rate for newly detected PTB+ cases.
The >85% cure rate was adopted on the basis of accumulated
experience in Africa and certain districts of China (5,6).
Performance indicators in the DOTS program use the pro-
portion detected of PTB+, which is the most infectious form
of TB. PTB+ is associated with high mortality (7) and is the
most effective form of TB to use for bacteriologic monitoring
of treatment progress (8). The proportion of newly detected
PTB+ cases among the total number of adults with PTB
reflects the proper application of diagnostic criteria. In coun-
tries with a medium or high TB burden, when necessary labo-
ratory resources are available and sputum smears for
microscopy are taken from TB patients, PTB+ accounts for
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* Cure: person who became sputum-smear–negative in the last month of
treatment and on at least one previous occasion; treatment failure: person
who continued to have sputum-smear–positive status at >5 months during
treatment; treatment completed: person with PTB+ who completed treatment
but whose condition was not consistent with the criteria for either cure or
failure; died: person who died of any cause during treatment; defaulter: person
who interrupted the treatment regimen for >2 consecutive months; and transfer
out: person who moved to another health-care facility and was entered in a
new diagnostic category (i.e., transfer in).
>50% of all TB cases and >65% of new PTB cases in adults
(3,9). Achieving a high (i.e., >85%) cure rate for PTB+ is a
critical priority for TB-control programs (3,9). Failure to
achieve this rate results in continued infectiousness and pos-
sible development of multidrug-resistant (MDR) TB, which
is resistant to at least isoniazid and rifampicin (10,11).
During 1980–1994, the countrywide TB notification rate
per 100,000 population decreased from 88.2 to 59.7. How-
ever, since 1995, notification rates have increased constantly,
reaching 165.1 in 2002. TB mortality rates per 100,000 popu-
lation decreased from 17.2 in 1980 to 10.6 in 1991. During
1992–1998, mortality rates increased, reaching 38.4 in 1998;
however, rates decreased to 24.2 in 2002 (Kazakhstan Minis-
try of Health [MoH], unpublished data, 1980–2002).
Increased TB mortality and morbidity have been attributed
to socioeconomic changes and the deterioration of the health-
care system in Kazakhstan after the country gained its inde-
pendence from the former Soviet Union in 1991 (12,13).
To manage the increasing burden of TB in the country, in
1998, the Kazakhstan MoH adopted and implemented a new
National Tuberculosis Program (NTP), whose objectives and
target goals are in accord with the DOTS strategy (14). To
implement the DOTS strategy in Kazakhstan, primary health-
care physicians and TB specialists received training in case-
detection policy, and laboratories were equipped with binocular
microscopes. During 1997–2000, the number of sputum-
smear examinations increased from 661,000 to 1,170,000
(Kazakhstan MoH, unpublished data, 2001).
Since 1998, a uniform TB surveillance system has operated
in Kazakhstan. Beginning in 2000, all administrative territo-
ries collected surveillance data. In 2003, CDC conducted a
study to evaluate NTP performance. Annual data for 2000–
2002 were analyzed to describe patterns of PTB notification
by person and place, assess progress toward achieving NTP




The MoH surveillance database in Kazakhstan was analyzed
to estimate the PTB notification rate and describe NTP per-
formance indicators that could be used to measure progress.
Selection of appropriate progress indicators was guided by
WHO recommendations (15). Two performance indicators
were selected: the proportion of new PTB+ cases among
reported cases of PTB among adults and the proportion of
persons with newly detected PTB+ cases who were cured (3).
Persons in the database, registered during 2000–2002, with
new PTB+ cases for which records for DOTS treatment regi-
men were completed by the time of the study were treated as
members of a cohort that was used to study associations
between treatment outcome and risk factors. The study was
given institutional review board approval by the Kazakh
State Medial University ethics committee.
Study Definitions
Diagnostic categories for newly reported cases of PTB (both
PTB+ and sputum-smear–negative PTB) and treatment out-
comes* for newly diagnosed PTB+ were defined in accordance
with WHO guidelines (3). To study the associations among
treatment outcome and risk factors, a new bi-level treatment
outcome variable was defined on the basis of the DOTS out-
come definitions: favorable (i.e., cured) and unfavorable (i.e.,
failed, died, or defaulted). Patients classified as having com-
pleted treatment or transferred out were excluded from the
risk factor analysis because either information was lacking
regarding alteration of sputum-smear status from positive to
negative or they had been classified according to a new diag-
nostic category. Sociodemographic and behavioral variables
in the surveillance database that were available for risk factor
analysis included age, sex, place of residence, homelessness,
employment status, employment in the medical profession,
previous incarceration, and alcohol abuse. These variables were
complete for >95% of records. Data were recorded by treat-
ing physicians at the time of TB diagnosis (5–10 days after
hospital admission) on the basis of information provided by
patients.
Data Sources
By law, TB is a reportable disease in Kazakhstan. A stan-
dard notification form is completed by the treating physician
and then entered into an electronic database when a patient
receives a TB diagnosis in any TB treatment facility. The
national TB surveillance database contains nonidentified
information on cases among civilians from all 16 administra-
tive regions (14 provinces and two large urban areas [Astana
and Almaty]); data on prisoners and military personnel are
not included in this database. During 2000–2002, a total of
99,111 extrapulmonary and pulmonary cases were registered
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FIGURE. Average annual notification rate* of new cases of
pulmonary tuberculosis (N = 65,011), by age group and sex —
Kazakhstan, 2000–2002












in the database; 65,011 (65.6%) were newly diagnosed PTB
cases that were used for the descriptive analysis. Of these, 803
(1.2%) persons were excluded from the analysis because of
lack of data on bacterioscopic investigation. Of 27,171 per-
sons in the database with newly diagnosed PTB+, complete
outcome data were available for 20,461 (75.3%) persons and
were used for the risk factor analysis. Of these, 285 (1.4%)
were children aged <15 years; because of these limited num-
bers, children were not included in the risk factor analysis.
Population denominator data were obtained from the National
Census Office of Kazakhstan.
Statistical Analyses
Data analyses were performed using Epi Info, version 3.2
(CDC, Atlanta, Georgia). Population estimates at midpoint
of the 2000–2002 study period were used to calculate the
average annual notification rates for new PTB by sex, age,
and region. Chi-square tests were used to evaluate differences
in notification rates and estimated target indicators by region.
Logistic regression analysis was used to study associations
between the study-defined treatment outcome variable and
sociodemographic and behavioral risk factors. All variables that
were significant at the two-sided α = 0.05 level in univariate analy-
ses were included in the final multivariate logistic model;
adjusted odds ratios (AORs) were used as measures of association.
Results
Descriptive Statistics
During 2000–2002, the countrywide average annual PTB
notification rate was 146 per 100,000 population. Rates in
urban and rural areas were similar (146.1 and 144.9, respec-
tively). However, rates differed significantly (p<0.001) by
region (range: 65.0 [Almaty City]–274.0 [Kzyl-Orda]). In gen-
eral, the highest rates were observed in the country’s western
regions (Actobe, Atirau, Mangistau, and West Kazakhstan).
Age-specific rate patterns were similar for men and women.
The highest rates occurred among persons aged 25–34 years
(men: 277; women: 241). Among persons aged >25 years,
rates were consistently higher for men than for women (Figure).
By region, significant differences were reported in the pro-
portion of sputum-smear–positive cases among adults with
newly reported PTB cases (range: 34.5% [Astana]–59.6%
[Northern Kazakhstan]) (p<0.001) (Table 1); no region
attained the goal of >65%. The cure rate for persons with new
PTB+ cases varied (range: 65% [Eastern Kazakhstan]–81%
[Almaty City]) (p<0.001) (Table 2). No region attained the
goal of >85%. Among 99,111 persons with TB, 100 (0.1%)
human immunodeficiency virus (HIV)–infected patients were
identified during the study period.
Risk Factor Analysis
Among 20,176 persons aged >15 years, 547 (2.7%) patients
had finished the treatment course but their sputum-smear
status was unknown, and 650 (3.2%) patients were transferred
out; both groups were excluded from the risk factor analysis.
Of 18,979 patients included in the analysis, 4,422 (23.3%)
had unfavorable treatment outcomes (i.e., died, failed, or
defaulted). The proportion recorded as having an unfavor-
TABLE 1. Number of reported new pulmonary tuberculosis
(PTB) and PTB smear-positive (PTB+) cases among adults,
by region — Kazakhstan, 2000–2002
No. of new PTB+ cases
Region PTB cases No. (%)
North Kazakhstan 2,582 1,538 (59.6)
Kostanay 4,061 2,309 (56.9)
Almaty 4,337 2,147 (49.5)
Acmolensk 3,962 1,931 (48.7)
Almaty City 2,154 1,038 (48.2)
Jambilsk 3,716 1,715 (46.2)
Karaganda 5,494 2,455 (44.7)
Kzyl-Orda 4,525 1,979 (43.7)
Atirau 2,747 1,199 (43.6)
Mangistau 1,988 855 (43.0)
West Kazakhstan 3,247 1,361 (41.9)
Actobe 4,071 1,694 (41.6)
East Kazakhstan 5,398 2,196 (40.7)
Pavlodar 3,729 1,498 (40.2)
South Kazakhstan 6,122 2,277 (37.2)
Astana City 1,772 612 (34.5)
Total 59,905 26,804 (44.7)
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notification rates were higher among males. Similar results
have been reported in other countries (18–20). The reasons
for this difference in TB notification rates are not known. No
evidence exists that health-seeking behaviors are substantially
different in countries of the former Soviet Union and could
not have accounted for male-female differences. Genetic fac-
tors or transmission dynamics might explain this difference.
During 2000–2002, the proportion of PTB+ cases among
the total number of new PTB cases among adults in Kazakhstan
was 44.7% (program target: >65%). In certain areas, the pro-
portion was lower (e.g., Astana-City: 34.5%; South
Kazakhstan: 37.2%). The DOTS strategy was adopted recently
(i.e., in 1998), and the quality of laboratory services and the
application of the diagnostic criteria might not be up to the
required standard, especially in certain areas.
Since the DOTS strategy was implemented, the supply of
primary TB drugs in TB-treatment facilities has been adequate;
consequently, this factor cannot explain the low cure rate for
new PTB+ cases, especially in certain regions (e.g., East
TABLE 2. Number of new pulmonary tuberculosis sputum-
smear–positive (PTB+) cases* and cure rates, by region —
Kazakhstan, 2000–2002
No. of new Cured
Region PTB+ cases No. (%)
Almaty City 834 676 (80.8)
South Kazakhstan 1,649 1,321 (80.1)
Kzyl-Orda 1,540 1,201 (78.0)
Astana City 359 272 (75.8)
Atirau 895 669 (74.9)
North Kazakhstan 1,288 962 (74.7)
West Kazakhstan 1,036 769 (74.2)
Jambilsk 1,285 937 (73.0)
Kostanay 1,867 1,353 (72.5)
Almaty 1,742 1,252 (71.9)
Acmolensk 1,500 1,070 (71.3)
Actobe 1,088 762 (70.1)
Mangistau 662 453 (68.4)
Karaganda 1,755 1,160 (66.1)
Pavlodar 1,236 804 (65.0)
East Kazakhstan 1,725 1,119 (64.9)
Total 20,461 14,780 (72.2)
* Occurring among persons for whom complete treatment outcome data
were available.
TABLE 3. Number and percentage of persons with new sputum-smear–
positive pulmonary tuberculosis (PTB+) cases, by selected demographic
characteristics and type of analysis — Kazakhstan, 2000–2002
New PTB+ cases Univariate Multivariate
(N = 18,979) (crude) analysis analysis
Characteristic No. (%) COR* (95% CI†) AOR§ (95% CI)
Residence
Urban 10,309 (54.4) 1.5 (1.4–1.6) 1.4 (1.3–1.5)
Rural¶ 8,649 (45.6) 1.0 1.0
Sex
Male 11,938 (62.6) 1.5 (1.4–1.6) 1.2 (1.1–1.3)
Female¶ 7,041 (37.4) 1.0 1.0
Alcohol abuse
Yes 762 (4.0) 3.2 (2.8–3.7) 2.1 (1.8–2.5)
No¶ 18,203 (96.0) 1.0 1.0
Homeless
Yes 313 (1.7) 3.4 (2.7–4.3) 2.2 (1.7–2.7)
No¶ 18,653 (98.3) 1.0 1.0
Previous incarceration
Yes 1,043 (5.5) 1.8 (1.6–2.1) 1.5 (1.3–1.7)
No¶ 17,923 (94.5) 1.0 1.0
Unemployed
Yes 11,614 (61.2) 1.4 (1.3–1.5) 1.5 (1.4–1.6)
No¶ 7,364 (38.8) 1.0 1.0
Medical personnel
Yes 229 (1.2) 0.5 (0.3–0.7) 0.6 (0.4–0.9)
No¶ 18,736 (98.8) 1.0 1.0
Age group (yrs)
15–24¶ 4,340 (23.0) 1.0 1.0
25–34 5,316 (28.0) 1.4 (1.2–1.5) 1.3 (1.1–1.4)
35–44 4,324 (23.0) 1.9 (1.7–2.1) 1.7 (1.5–1.9)
45–54 2,723 (14.0) 2.4 (2.1–2.7) 2.1 (1.9–2.4)
55–64 1,376 (7.0) 2.2 (1.9–2.6) 2.3 (2.0–2.7)
>65 900 (5.0) 2.3 (1.9–2.6) 2.8 (2.3–3.3)




able outcome varied by age group. In univariate
analyses, all studied variables were statistically sig-
nificant at the 0.05 level and were included in the
final multivariate logistic model. Unfavorable treat-
ment outcomes for new PTB+ cases were associ-
ated with alcohol abuse, homelessness, previous
incarceration, unemployment, being male, and ur-
ban residence. Being medical personnel was pro-
tective. AORs for unfavorable treatment outcomes
increased with age (Table 3).
Discussion
The high countrywide notification rate of new
PTB cases (146 per 100,000 population for the
3-year study period) underscores the importance
of controlling TB in Kazakhstan. Substantial
regional differences were recorded; in certain
areas (e.g., Kzyl-Orda, 274 per 100,000 popula-
tion), the notification rate was approximately twice
the national average. As in other countries, regional
differences might result from different underlying
socioeconomic conditions and the quality of the
performance of local TB-control programs (16,17).
Further research is needed to identify the reasons
for regional differences, so corrective measures can
be taken as needed.
The age-specific notification rate of new PTB
cases was similar for children aged <15 years for
both sexes. However, for persons aged >15 years,
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Kazakhstan and Pavlodar, both 65%). Data were not available to
explore reasons for the low cure rate (e.g., the prevalence of
MDR-TB). The single study available indicated that high
(14.2%) MDR-TB rates among new TB patients in Kazakhstan
might contribute to a low cure rate in the country (21).
Unemployment and urban place of residence were highly
prevalent (>54%) in the study group and associated with
unfavorable treatment outcomes; this could have contributed
to the low cure rate. Other factors (i.e., homelessness, history
of incarceration, alcohol abuse, and age >55 years) had more
effect on the unfavorable treatment outcome; however, their
overall effect on the cure rate might have been limited
because of low prevalence.
Among medical personnel, the protective odds ratio for
unfavorable treatment outcome (AOR = 0.6) might be
explained by their stricter adherence to treatment regimen. The
high percentage of unfavorable treatment outcomes among per-
sons aged >55 years was attributable to deaths from any cause;
however, among persons in other age groups, the majority of unfa-
vorable treatment outcomes were attributable to treatment failure.
Kazakhstan is in the beginning stage of an HIV epidemic.
During 2000–2002, a total of 100 (0.1%) cases of HIV were
identified among 99,111 persons with TB. The contribution of
HIV infection to the TB burden is believed to be insubstantial.
The findings in this report are subject to at least one limita-
tion. All study factors were measured by the treating physi-
cians on the basis of patient self-reports. Patients might not
have reported certain behaviors, particularly those regarded
as socially unacceptable (e.g., alcohol abuse). As a result, the
low prevalence of these behaviors among TB patients and their
consequent low overall impact on the cure rate might reflect
inaccurate self-reporting.
Continued evaluation is needed to improve performance of
the TB program in Kazakhstan. Improving program indicators
requires evaluation of detection efforts, laboratory diagnostic
capabilities, and adherence to treatment regimens, especially in
provinces where rates are high and among persons at high risk for
unfavorable treatment outcomes, so recommendations for im-
provement can be offered as needed. In addition, laboratory quality
control and quality assurance for TB culture should be further
implemented in the country to assist in assessing the impact of
MDR TB on the cure rate of PTB patients.
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Abstract
Introduction: As part of the global strategic plan to reduce the number of measles deaths in India, the state of Tamilnadu
aims at >95% measles vaccination coverage. A study was conducted to measure overall coverage levels for the Poondi Primary
Health Center (PPHC), a rural health-care facility in Tiruvallur District, and to determine whether any of the PPHC’s six
health subcenters had coverage levels <95%.
Methods: The Lot Quality Assurance Sampling (LQAS) method was used to identify health subcenters in the PPHC area
with measles vaccination coverage levels <95% among children aged 12–23 months. Lemeshow and Taber sampling plans
were used to determine that the measles vaccination status of 73 children aged 12–23 months had to be assessed in each health
subcenter coverage area, with a 5% level of significance and a decision value of two. If more than two children were unvac-
cinated, the null hypothesis (i.e., that coverage in the health subcenter was low [<95%]) was not rejected. If the number of
unvaccinated children was two or fewer, the null hypothesis was rejected, and coverage in the subcenter was considered to be
good (i.e., >95%). All data were pooled in a stratified sample to estimate overall total coverage in the PPHC area.
Results: For two (33.3%) of the six health subcenters, more than two children were unvaccinated (i.e., coverage was <95%).
Combining results from all six health subcenters generated a coverage estimate of 97.7% (95% confidence interval = 95.7–98.8)
on the basis of 428 (97.7%) of 438 children identified as vaccinated.
Conclusion: LQAS techniques proved useful in identifying small health areas with lower vaccination coverage, which helps
to target interventions. Monthly review of vaccination coverage by subcenter and village is recommended to identify pockets of
unvaccinated children and to maintain uniform high coverage in the PPHC area.
Introduction
The goal of the World Health Organization’s global measles
strategic plan is to reduce by half the estimated number of
measles deaths by 2005 compared with 1999 estimates (1).
The target goal set by the Indian Ministry of Health and Family
Welfare is to reduce measles mortality 66% by 2010 com-
pared with 2000 estimates (2). Increasing, sustaining, and
documenting high routine coverage is essential to achieve sus-
tainable reduction of measles mortality.
The southern Indian state of Tamilnadu has set three objec-
tives for its measles control program: 1) measles vaccination
coverage of >95% through routine vaccination of children
aged 9–12 months, 2) ring vaccination after occurrence of
measles cases, and 3) treatment of ill persons to prevent com-
plications. To evaluate progress toward achieving the first
objective, the Field Epidemiology Training Programme and
local public health officials estimated coverage levels by using
a Lot Quality Assurance Sampling (LQAS) survey (3). This
evaluation was conducted for fiscal year 2002–2003 (April 1,
2002–March 31, 2003) to identify health subcenters with
measles vaccination coverage of <95% among children aged
12–23 months and to estimate the overall measles vaccina-
tion coverage in the same age group in the primary health
center area.
LQAS is a stratified random sampling method in which small
samples randomly selected from each stratum are used to
determine whether coverage in a stratum exceeds a specific
threshold. Compared with the commonly used cluster survey
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* A primary health center is a basic health unit staffed by a medical officer and
health team that provides integrated curative and preventive health-care
services to a rural population of approximately 20,000–30,000 persons. A
health subcenter is a peripheral outpost staffed by an auxiliary nurse midwife
who provides primary health-care services (e.g., mother-and-child care, family
planning, and vaccination) for a population of approximately 3,000–5,000
persons.
technique, LQAS can be used to identify areas with low vacci-
nation coverage (3). The operational feasibility of LQAS to
evaluate vaccination coverage among limited population units
in India has been demonstrated (4,5).
Methods
In April 2003, the LQAS survey was conducted in the Poondi
Primary Health Center (PPHC) area, Tiruvallur District,
Tamilnadu, India. This primary health center serves approxi-
mately 27,000 persons distributed in six health subcenter
areas (approximately 4,500 persons per health subcenter).*
Sampling Methods
A simple random sample of the population served by PPHC
was used, divided into six strata representing the six health
subcenters. District health authorities expected measles cov-
erage in the PPHC area to be >95%. A decision value (d) of
two nonimmunized children and an acceptable alpha value of
0.05 were set. On the basis of this information, sample size
(n) was estimated by using Lemeshow and Taber LQAS tables
(6). A plan with n = 73 was used; this single-stage sampling
plan accepted an alpha error of 5%. In each health subcenter,
the total number of eligible children (i.e., those aged 12–23
months) available was assumed to be 100. Within each stra-
tum, 73 children were assessed for measles vaccination status,
for an overall sample of 438 children in the PPHC area.
Each health subcenter included multiple villages. To deter-
mine the number of children to be selected in each village in
each stratum, a list of villages was constructed for each stra-
tum with the number of households and the cumulative num-
ber of households; 73 random numbers were selected using
random number tables. Once the number of children had been
determined for each village, researchers randomly selected as
many households as children were needed. For each selected
household, any eligible child was included. When no eligible
child was identified in the house, the next houses to the right
were surveyed until an eligible child was identified. When more
than one eligible child was present in a house, only the youngest
one was included. Children’s ages were estimated using birth
certificates or any other records showing the date of birth.
When no written documentation was available, the age given
by the mother or the guardian was used.
Only those children who received measles vaccination at age
9–12 months were considered vaccinated. The measles vacci-
nation status of the child was obtained by reviewing vaccina-
tion cards if available or by interviewing the mother or guardian
when cards were not available. Children were excluded from
the survey if a parent or guardian was not available.
Analysis of the Survey
Two analyses were conducted, an LQAS analysis in each
stratum and a pooled analysis for the total sample. Card
availability in subcenters varied (range: 7%–37%). The LQAS
analysis in each stratum was based on testing a hypothesis.
The null hypothesis (Ho) was that the coverage in the health
subcenter was <95% (Ho: p<95%, low performance). The
alternate hypothesis (Ha) was that the coverage in the health
subcenter was >95% (Ha: p>95%, high performance). In each
stratum of 73 persons, two (2.7%) persons were considered
as the decision value (i.e., the threshold for analysis). In prac-
tice, when more than two of 73 children were identified as
unvaccinated, coverage in the stratum was considered to be
<95%. If no more than two unvaccinated children were iden-
tified, coverage in the stratum was considered to be >95%. All
data were pooled to estimate overall total PPHC coverage.
Overall measles vaccination coverage was calculated from the
total number of eligible children vaccinated compared with
the total number of eligible children surveyed. Because this
was a simple random sample, with no design effect, best esti-




In two health subcenters (Neyveli and Vellathukkottai), more
than two children were unvaccinated, and vaccination coverage
was considered to be <95% (Table). In the other four subcenters
(Chitampakkam, Meyyur, Nambakkam, and Poondi), the num-
ber of unvaccinated children did not exceed two, and vaccina-
tion coverage was considered to be >95% (Table).
Pooled Analysis
The pooled analysis was made on the basis of an overall
sample of 438 children (73 from each subcenter). Of these,
428 (97.7%) had been vaccinated against measles, and overall
measles vaccination coverage in Poondi was considered to be
97.7% (CI = 95.7%–98.8%) (Table).
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TABLE. Measles vaccination coverage, by health subcenter — Poondi Primary
Health Center, Tiruvallur District, Tamilnadu, India, 2002–2003*
Coverage
No. of children Estimate
Health subcenter Surveyed Vaccinated Unvaccinated LQAS† (95% CI§)
Neyveli 73 69 4 <95% NA¶
Vellathukkottai 73 70 3 <95% NA
Meyyur 73 71 2 >95% NA
Chitampakkam 73 72 1 >95% NA
Poondi 73 73 0 >95% NA
Nambakkam 73 73 0 >95% NA
Total 438 428 10 NA 97.7%
(95.7%–98.8%)
* Fiscal year 2002–2003 (April 1, 2002–March 31, 2003).




This study determined that the overall vaccination cover-
age level in the PPHC area was 97.7%, which is consistent
with the state target level of >95%. Two (33.3%) subcenters
had coverage levels below the target level of >95%; these
results were used to target interventions to these low-coverage
areas.
LQAS techniques provide a rapid and simple determina-
tion of output quality and are used in industry for quality-
assurance purposes. The strategy and goals of LQAS in the
health field are similar to those in the manufacturing field
(7). LQAS analysis is based on testing a hypothesis rather than
on estimating a proportion. Because LQAS is based on strati-
fied random sampling, results from lot samples can be com-
bined to obtain a point estimate for the entire population,
allowing for a small sample size. LQAS procedures were use-
ful for identifying small health areas with lower measles vacci-
nation coverage. This information, combined with further
assessment of performance problems and timely corrective
action, has been used to improve vaccination coverage in the
district. LQAS techniques also could be used to assess perfor-
mance as part of routine monitoring or supervisory activities
of routine vaccination.
For a vaccination program to achieve its goal, a sufficient
number of doses must be administered at the appropriate ages.
Coverage levels are therefore a key process indicator of perfor-
mance. Monitoring this indicator at the population level pro-
vides an overall assessment of program performance.
Operational units with poorer coverage should be identified
so performance can be improved (8). LQAS techniques are a
particularly useful way of monitoring indicators of coverage,
as these techniques provide a rapid and simple determination
of output quality.
On the basis of the results of the study, an analy-
sis of vaccination coverage by health subcenter
and village during regular monthly review meet-
ings was recommended to identify missed pock-
ets of unvaccinated children and to continue
efforts to maintain uniform high vaccination cov-
erage in the PPHC area. The recommendation
was followed by all the medical officers and helped
them identify groups of unvaccinated children
and improve the measles vaccination coverage.
No outbreaks of measles were reported subse-
quently in the study area. However, measles sur-
veillance was limited by the unavailability of
long-term trend data, and the validity of the
surveillance system has not been estimated.
The findings of this study are subject to at least
one limitation. Vaccination cards were available for only 91 (21%)
of 438 children surveyed, which could have resulted in overesti-
mating measles vaccination coverage. The supply of vaccination
cards was limited, and those parents who did receive cards often
did not preserve them. To aid in future surveys, a sufficient quan-
tity of vaccination cards should be made available to health workers
in each health subcenter. This will facilitate monitoring and evalu-
ation efforts. Health workers should be trained to understand the
importance of the cards and how to use them properly, and fami-
lies should be educated to understand the need to keep the cards in
a safe place.
In December 2004, an outbreak of measles was reported in
the Cuddalore district of Tamilnadu. Estimated measles vacci-
nation coverage was approximately 96% (9), indicating that a
measles outbreak can occur among a well-vaccinated popula-
tion when a single-dose measles vaccination strategy is employed.
A substantial measles outbreak also was reported during 1999–
2000 in Sri Lanka, where single-dose measles vaccination
coverage since 1996 was >90% (10). For future measles out-
breaks in an area with a single-dose measles schedule to be pre-
vented, a possible strategy to provide a second dose might be
considered.
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Abstract
Introduction: In July 2002, a cluster of bacterial meningitis (BM) cases was identified among European cochlear implant
recipients (CIRs), prompting Health Canada to conduct a retrospective cohort study to determine the rate of BM infection
among Canadian CIRs and to identify risk factors for acquiring BM.
Methods: A survey was mailed to 1,432 Canadian CIRs who had received implants during January 1995–July 2002 to
assess occurrence of postimplant BM infection. Data collection included demographics, episodes of meningitis, and vaccina-
tion status.
Results: A total of 1,024 (72%) surveys were completed. Median age of CIRs at implantation was 16 years (range: 7 months–
81 years). Five (0.5%) cases of BM infection were reported (two pneumococcal, one meningococcal, and two of unknown
etiology); one CIR died. Four cases occurred among children aged <18 years. Time between implantation and BM infection
varied (range: 7 months–7.7 years; median: 11 months). The rate of BM infection per 1,000 person-years was 0.7 among
CIRs aged >18 years and 2.9 among those aged <18 years. The proportion of CIRs vaccinated against pneumococcal and
meningococcal disease was low (46% and 41%, respectively). Preimplant meningitis was identified as a risk factor for
postimplant BM (p = 0.002). No other risk factors evaluated were associated with an increased risk for BM infection.
Conclusion: CIRs have a high rate of postimplant BM infection. Preimplant BM infection was identified as a risk factor.
Cases of BM infection might have been prevented through vaccination.
Introduction
Meningitis is an inflammation of the lining of the brain’s
surface, often as a result of a bacterial or viral infection. Chil-
dren aged <2 years are most at risk for meningitis. Among
infants, early symptoms of meningitis include fever, irritabil-
ity, lethargy, and loss of appetite. Among children and adults,
other symptoms might include headache, stiff neck, photo-
phobia, nausea and vomiting, and confusion or alteration in
consciousness (1).
Cochelar implants are medical devices that electronically
stimulate the auditory nerves in the cochlea (inner ear),
allowing persons with severe hearing loss to perceive sound.
In early July 2002, a cluster of cases of bacterial meningitis
(BM) infection was identified among European cochlear
implant recipients (CIRs) who had received an implant pro-
duced by manufacturer A (2). European implant surgeons had
hypothesized that the cluster of BM infections they had
observed among their patients might be related to a recently
licensed cochlear implant device (device A) produced by manu-
facturer A (2). This device differed from other similar manu-
factured devices in that it had two components, an electrode
array and a positioner, rather than a single electrode array.
The positioner increased electrical signal transmission to the
auditory nerve, particularly among patients with malforma-
tions of the cochlea. On July 23, manufacturer A issued a
voluntary recall of the device in France (3). After discussions
with the European regulatory authorities, manufacturer A sub-
sequently issued a voluntary worldwide withdrawal of the
device. On July 26, the two-piece device, which had been
licensed for use in Canada in November 1998, was withdrawn
from the Canadian market.
On July 29, Health Canada issued an alert warning that
CIRs might be at greater risk for meningitis (4). Subsequently,
the Immunization and Respiratory Infections Division of
Health Canada (now the Public Health Agency of Canada)
investigated the extent of BM infection among CIRs in
Canada. To understand the magnitude of this problem in
Canada, a retrospective cohort study was conducted. The three-
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TABLE 1. Number and percentage of cochlear implant recipients
(CIRs), by selected characteristics — Canada, 2002
Characteristic No. (%)
Age at time of implant
Pediatric (<18 yrs) 482 (47.5)
Adult (>18 yrs) 532 (52.5)
Median: 16 yrs








Before January 1, 1999 294 (35.2)
On or after January 1, 1999 541 (64.8)
Bacterial meningitis before implant
Yes 71 (7.3)
No 905 (92.7)





Meningococcal serogroup C 381 (41.1)
Hib* 369 (40.0)
Received vaccination before implant†
Pneumococcal 40 (11.6)
Meningococcal serogroup C 32 (10.9)
Hib 155 (55.4)






Household smoker 279 (22.9)
Other household children 275 (26.9)
Child care attendance 320 (31.5)
* Haemophilus influenzae type b.
†Certain CIRs were not old enough to be eligible for vaccination before
implantation.
§ Includes middle-ear tubes and ventribuloperitoneal and endolymphatic
shunts.
fold purpose of the investigation was to determine the rate of
BM among CIRs in Canada, identify risk factors for
postimplant BM, and recommend public health action based
on investigation findings.
Methods
The study cohort included all 1,432 recipients of cochlear
implant devices in Canada with implant dates during January
1995–July 2002. Cohort members were identified using manu-
facturer implant registries. At the time of the study, two manu-
facturers were licensed in Canada. A case was defined as one
occurring in a CIR who reported having BM infection since
receiving an implant.
A self-administered questionnaire in both French and
English was mailed to CIRs or, if deceased, their next of kin.
The questionnaire was designed by modifying tools developed
for a similar investigation in the United States (5). The survey
was completed by the recipient or by a parent or guardian if
the recipient was aged <16 years or was incapable of complet-
ing the survey. Questions addressed included cause of hearing
loss, history of meningitis infection, vaccination status, and
risk factors (e.g., household smoking, other children in the
household, and otitis media infections). Questions were
divided into two periods: before and after receiving a cochlear
implant. Only nonnominal data were collected. Data were
collected during November 25, 2002–March 31, 2003. To
obtain the highest response rate possible to the mailed ques-
tionnaire, Dillman’s Total Design Method for mailed surveys
was followed, with certain modifications (6). Ethics approval
for the study was obtained from Health Canada’s Research
Ethics Board.
Data were entered in EpiData 2.1a (The EpiData Associa-
tion, Odense, Denmark, 2001–2002). Univariate and
bivariate analysis, including relative risks and chi-square tests,
were conducted using Epi Info 6.04d (CDC, Atlanta, Geor-
gia). To determine if the introduction of the two-piece
implant affected incidence of BM infection, data were strati-
fied by implant manufacturer and date of implant (i.e., before
and after January 1, 1999, when the two-piece implant device
was licensed in Canada).
Results
A total of 1,024 CIRs completed and returned the survey
(overall response rate: 72%). Median follow-up time (from
implant to BM infection or end of the study period) for CIRs
was 42 months (Table 1). Among respondents, males and
females were equally represented, and approximately half
(n = 482) were aged <18 years. Manufacturers were repre-
sented in proportion to their market share (approximately 33%
for manufacturer A and 67% for a second manufacturer
[manufacturer B]).
Among 98 CIRs who had an episode of meningitis infec-
tion before receiving a cochlear implant, 71 (72%) had infec-
tions that were bacterial. Of seven cases of meningitis
reported after a cochlear implant, five (71%) were bacterial;
the type of bacteria was reported for three cases. Two CIRs
reported Streptococcus pneumoniae as the causative agent, and
one reported Neisseria meningitidis (Table 2). None of the BM
episodes occurred during the perioperative period (0–30 days
postimplantation).
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Age group (yrs)* Sex BM Type vaccination and infection Outcome
1–4 Male No Pneumococcal No 20 mos Recovered
5–9 Female No Unknown —† 7 mos Recovered
10–14 Female Yes Meningococcal No 11 mos Died
15–17 Male Yes Pneumococcal No 7 yrs, 9 mos Recovered
65–70 Female Yes — — 12 mos Recovered
* No cases occurred among persons aged 18–64 years.
†No data available.
The overall incidence of BM infection for this cohort was
1.8 per 1,000 person-years of observation (95% confidence
interval [CI] = 0.6–4.2). Among CIRs aged <18 years, inci-
dence was 2.9 (CI = 0.8–7.3); among CIRs aged <6 years,
incidence was slightly lower (2.0; CI = 0.2–7.1). Incidence
among adults aged >18 years was 0.7 per 1,000 person-years
of observation (CI = 0.0–4.1).
Incidence of BM infection among adults aged >18 years
before and after 1999 did not vary (2.2 and 2.0 per 1,000 person-
years observation, respectively). Although not statistically
significant, incidence of BM infection among persons aged
<18 years was higher on or after January 1, 1999, than before
(4.0 and 2.2 per 1,000 person-years, respectively). Among chil-
dren aged <6 years, incidence was 1.5 (CI = 0.0–8.1) before
1999 and 3.1 on or after January 1, 1999 (CI = 0.1–17.2).
All five persons with BM infection had received meningo-
coccal vaccine, and four had received pneumococcal vaccine.
However, of the three persons for whom the causative agent
was known, none had received vaccination against the
implicated agent before the postimplant episode of meningitis.
Potential risk factors assessed for postimplant BM infection
included a history of otitis media, household smoking, and
children living in the household. None was statistically sig-
nificant (Table 3). A previous episode of BM infection was
identified as a risk factor for postimplant BM infection (rela-
tive risk [RR] = 23.1; CI = 3.2–197.3; p = 0.002). Having
had other implanted devices was associated with an increased
risk for BM infection; however, this association was not sta-
tistically significant (p = 0.081).
No difference in risk for BM infection by implant manu-
facturer was noted (p = 1.0). The cohort included recipients
who had received the device with a positioner; however, the
type of implanted device (with or without a positioner) was
not well reported, and whether the positioner was an inde-
pendent risk factor could not be determined.
Discussion
The rate of BM infection per 1,000 person-years among
CIRs aged >18 years was 0.7, compared with 2.9 among CIRs
aged <18 years. Results of a similar study of CIRs in the United
States during the same period have been published (5). Inci-
dence of BM infection among CIRs was 3.9 among U.S. chil-
dren aged <6 years, compared with 2.0 among Canadian
children in the same age group during the period when device
A was on the market. Although different methodologies were
used, certain key study questions were similar, allowing com-
TABLE 3. Number of cases and relative risk for postimplant
bacterial meningitis (BM) among cochlear implant recipients,




Characteristic cases) months*) (95% CI§)
BM before implant
Yes 3 2,003 23.1
No 2 30,920 (3.2–197.3)
Other implanted devices
Yes 2 3,380 6.0
No 3 30,573 (1.1–36.1)
Otitis media after implant
Yes 2 5,336 3.2
No 3 25,750 (0.5–19.2)
Child care attendance
Yes 1 11,402 0.4
No 4 17,593 (0.04–3.5)
Implant manufacturer
A 2 11,685 1.3
B 3 22,383 (0.2–7.6)
Child in household
Yes 1 9,139 0.7
No 4 25,086 (0.1–6.1)
Household smoker
Yes 1 10,820 0.5
No 4 23,358 (0.1–4.8)
* Number of months each study participant contributed to the study cohort.
†Relative risk, calculated by using the number of cases as the numerator
and the number of person-months of observation for each person in the
cohort as the denominator.
§Confidence interval.
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parisons between the two studies. In Canada, no cases of
perioperative BM infection were identified among CIRs,
whereas in the U.S. study, the rate of perioperative BM infec-
tion was 2.1 cases per 1,000 procedures (5). Why incidence
of perioperative infections is higher among CIRs in the United
States is not known.
These findings of increased incidence of BM infection
among CIRs aged <18 years since the device with the positioner
was introduced in 1998 are similar to findings published pre-
viously (5). No increased risk for BM infection was identified
among adult CIRs after the device with the positioner was
introduced.
In Canada, surveillance of invasive diseases (e.g., meningi-
tis) is organism specific and includes all forms of invasive dis-
ease. Incidence of invasive pneumococcal disease ranges from
11.6 to 17.3 per 100,000 population, whereas incidence of
invasive meningococcal disease ranges from 0.6 to 1.6 per
100,000 population (7,8), compared with an observed inci-
dence of 1.8 per 1,000 person-years among CIRs in this study.
CIRs have multiple potential underlying conditions that
might increase their risk for BM infection above that of the
general Canadian population. The ideal comparison group
for CIRs would be a population of severe-to-profoundly deaf
persons who do not have cochlear implants; however, such
data are not available. During 1994–2001, the overall annual
incidence of BM infection in the general Canadian popula-
tion ranged from 3.2 to 3.7 per 100,000 population (9).
Preliminary study results were presented to Canada’s
National Advisory Committee on Immunization (NACI). In
February 2003, NACI recommended that CIRs be consid-
ered at high risk for both Haemophilus influenzae type b (Hib)
and invasive pneumococcal disease and should receive vacci-
nation according to the high-risk schedule (10). In addition,
CIRs, like all Canadians, should be up-to-date on all routine
vaccinations, including meningococcal C conjugate vaccines.
These vaccines are recommended for all Canadian children
aged <5 years, adolescents, and young adults.
CIRs, their parents, and caretakers should be aware of the
signs and symptoms of meningitis and seek medical attention
if they occur. Medical professionals should be aware of the
potential for BM infection among CIRs, be vigilant for the
signs and symptoms of meningitis in this population, and
educate their patients accordingly. Primary health-care pro-
viders of CIRs or persons considering cochlear implants should
ensure that these persons are fully vaccinated according to
NACI guidelines (10).
The findings in this report are subject to at least four limi-
tations. First, the retrospective cohort was established by
using manufacturer registry data that were likely incomplete
and that did not contain the most recent mailing address of
every CIR in Canada. CIRs who did not register their
implant devices were not included in the cohort. However,
because incomplete mailing addresses were evenly distributed
among the two implant manufacturers, no selection bias was
likely introduced as a result. Second, as with all self-
administered questionnaires, reported medical histories might
not be accurate, particularly for adults who might have lost
their hearing many years before receiving a cochlear implant.
Third, medical details (e.g., type of meningitis and whether
treatment was received for episodes of otitis media) were poorly
reported. Response rates for medical details varied widely
(range: 40%–80%) compared with responses to other ques-
tions (e.g., ever having otitis media, ever having meningitis,
and cause of deafness [range: 90%–99%]). The cause of BM
was based on self-report and was not verified with medical
records. In addition, subtyping of bacteria that caused
postimplant BM was not reported. The type might not have
been vaccine preventable. Certain questions pertaining to vac-
cination history were misinterpreted. For example, Hib vac-
cine was often indicated as having been received yearly,
indicating confusion between Hib vaccine and annual influ-
enza vaccine. Finally, the study was conducted in English and
French. CIRs who could not read either of these languages
were systematically excluded from the cohort and might have
BM at a different rate from CIRs who read English or French.
Conclusion
In this study, CIRs had postimplant BM infection at a rate
of approximately 1.8 cases per 1,000 person-years of observa-
tion. In addition, children with cochlear implants had BM
infection at a higher rate than adults (2.9 and 0.7 per 1,000
person-years of observation, respectively). Because of the
increased risk for BM infection among CIRs, health-care pro-
fessionals should ensure that CIRs and persons considering
cochlear implants are vaccinated against bacteria that com-
monly cause meningitis. The only risk factor identified for
having postimplant BM was preimplant BM infection. CIRs
and their families should be aware of the signs and symptoms
of meningitis and seek prompt attention if they occur.
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Abstract
Background: Uganda has not achieved the 2005 neonatal tetanus (NNT) global elimination target set by the World Health
Organization (WHO). The Busoga region has the highest recorded level of NNT incidence in Uganda. To understand the
reasons for this high incidence, a study was conducted to identify NNT risk factors.
Methods: During March–May 2004, a matched case-control study was conducted in the Busoga region for a 2-year study
period (2002–2003). Matching variables were sex, residence, and date of birth. A total of 24 cases of NNT (according to the
WHO case definition) were identified from hospital records, and 96 community controls (children who survived the neonatal
period) were selected.
Results: Bivariate analysis indicated that neonates with NNT were more likely to have been delivered outside a health
facility, on an unclean surface, without use of gloves, or by unskilled attendants. Mothers of these neonates were less likely to
report vaccination during previous pregnancies, administration of 2 doses of tetanus toxoid (TT) during the study pregnancy,
or use of certain intravaginal substances (most commonly, herbs) at onset of labor. Multivariate analysis indicated that
unclean delivery surfaces (odds ratio [OR] = 38.8; 95% confidence interval [CI] = 2.9–518.1) and primigravidae mothers
(OR = 79.5; CI = 1.8–3,472.2) were associated with NNT. Administration of 2 doses of TT during pregnancy, vaccination
during previous pregnancies, and intravaginal application of certain substances were protective against NNT.
Conclusion: These findings underscore the importance of having clean delivery surfaces and of mothers receiving 2 doses of
TT during pregnancy. Implementation of these measures might help eliminate NNT from the Busoga region of Uganda.
Introduction
Neonatal tetanus (NNT) is a fatal yet preventable disease
that accounts for 14% of annual neonatal deaths worldwide
(1). In 1997, a total of 248,000 NNT deaths occurred glo-
bally; 95,000 NNT deaths occurred in Africa, 4,600 of which
occurred in Uganda (2). In 2000, the World Health Organi-
zation (WHO) targeted NNT for global elimination by 2005
(3). Uganda is one of the 57 countries that have not yet elimi-
nated NNT. In Uganda, with 195 cases, the Busoga region
has the highest NNT incidence (4). In 2002, the Uganda Min-
istry of Health (MoH) launched an NNT elimination cam-
paign in Busoga. After the second round of mass tetanus toxoid
(TT) immunization during the NNT elimination campaign,
approximately 86% of women of reproductive age in all dis-
tricts in the region had received 2 doses of TT (5).
A previous study attributed NNT in Busoga to unhygienic
delivery practices, application of harmful substances on the
umbilical cord, and lack of TT immunization among moth-
ers but did not document the magnitude of risk associated
with these factors (6). Worldwide, NNT has been associated
with prenatal, perinatal, and neonatal factors, including
unhygienic delivery and cord-care practices and lack of
maternal TT immunization (7). Risk for contamination and
subsequent occurrence of NNT remains high for several days
after delivery until the baby’s cord wound heals (8).
NNT cases continue to be reported in Busoga. For this rea-
son, district health teams in the region recommended that a
study be conducted to identify NNT risk factors as a basis for
planning and implementing appropriate NNT elimination
strategies.
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Methods
A community-based, matched case-control study was con-
ducted to identify delivery and umbilical cord-care practices
that predispose neonates to NNT and to compare maternal
TT immunization status for both groups. The study was con-
ducted during March–May 2004 in five districts that make
up the Busoga region (Bugiri, Iganga, Jinja, Kamuli, and
Mayuge). Respondents were the mothers of the neonates with
NNT and matched controls.
Mothers of neonates with NNT were identified by screen-
ing NNT investigation forms from all hospitals in the Busoga
region for January 2002–December 2003. A case was defined
as confirmed NNT according to the WHO case definition
(i.e., history of normal sucking and crying for the first 2 days
of life, onset of illness at age 3–28 days, and inability to suck
followed by generalized stiffness and/or spasms) occurring in
a child born in the Busoga region during the study period (5).
A control was defined as a child who had survived the neona-
tal period, who was matched for sex and date of birth (range:
±6 months), and who lived in the same village as a neonate
with NNT. A control was selected from each of the first four
households closest to the home of a child with NNT that had
a child consistent with the control definition. If a household
had more than one eligible control, the child whose date of
birth was closest to that of the neonate with NNT was selected.
Multiple controls were selected to increase the power of the
study (9). Children whose mothers did not live in the Busoga
region at the time of delivery were excluded from the study.
The questionnaire used was adapted from the WHO NNT
case investigation form (5). It was modified before the study
was conducted on the basis of qualitative data about the most
probable NNT risk factors collected from 80 mothers who
participated in eight focus group discussions and interviews
with eight traditional birth attendants. Questionnaires were
pretested among 20 Jinja district mothers who were not part
of the final study sample.
Trained interviewers used the pretested, interviewer-
administered questionnaire to collect data on maternal socio-
demographic characteristics, delivery practices, umbilical
cord-care practices, and maternal TT immunization status.
The delivery surface was categorized as clean or unclean; any
surface other than a new plastic sheet or operating theater
table was classified as unclean. The mother of a neonate with
NNT was always interviewed before that of the controls to
ensure accurate matching. The Uganda National Council of
Science and Technology and Makerere University Institute of
Public Health Higher Degrees Research and Ethics Commit-
tee approved this study, and all participating mothers signed
consent forms.
Data were double-entered and validated by using Epi Info
6.04 (CDC, Atlanta, Georgia). Epi Info also was used for
bivariate analysis; stratified Mantel-Haenszel analysis produced
matched odds ratios (ORs) and 95% confidence intervals
(CIs). For multivariate analysis, data were exported to SPSS
10.0 (Statistical Package for the Social Sciences for Windows,
version 10.0; SPSS; Chicago, Illinois); conditional
logistic regression was performed to identify the predictors
for NNT. All variables entered in the model were dichoto-
mized, with neonatal tetanus case (Yes/No) as the outcome
variable. The initial logistic regression model included all vari-
ables that were statistically significant during bivariate analy-
sis (e.g., delivery place, birth attendant, delivery surface, use
of intravaginal substances, use of gloves, maternal TT status
in study, and previous pregnancies). Other variables that were
not significant on bivariate analysis but that are known risk
factors for NNT (e.g., handwashing, type of cord-cutting tool,
cord dressings, and cord tie used) and potential confounders
(e.g., maternal age) also were included in the model. Mea-
sures of interest were adjusted ORs and CIs for NNT risk
factors. Goodness of fit of the final model was tested by using
Nagelkerke R2 value.
Results
A total of 40 NNT cases were identified from the records,
but only 24 mothers could be traced in the community. Full
names were not available for three mothers, and addresses of
nine mothers were not recorded in the hospital records. In four
cases, parents had moved and could not be located. Four
matched controls were selected for each of the 24 cases, for a
total of 96 controls and a study sample of 120.
Bivariate Analysis
The majority of neonates with NNT and controls had moth-
ers who were aged >20 years, were currently married, and had
attained at least a primary education (Table 1). The percent-
age of mothers who were primigravidae (i.e., this was their
first pregnancy) was 25% for neonates with NNT and 12.5%
for controls. The majority of mothers (17 [70.8%] of 24 neo-
nates with NNT and 62 [64.6%] of 96 controls) had had one
to four previous deliveries. No statistically significant associa-
tions were observed between maternal sociodemographic char-
acteristics and NNT.
Maternal TT immunization status of the two study groups
was compared (Table 2). Maternal TT immunization status
was determined by history because only 12.5% of mothers
whose neonates had NNT and 26% of controls had TT
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TABLE 1. Number and percentage of neonates with neonatal tetanus
(NNT) and controls, by selected maternal characteristics — Busoga
region, Uganda, 2002–2003
Children
with NNT Controls Matched
Characteristic No. (%) No. (%) OR* (95% CI†)
Maternal age (yrs)
<20 3 (12.5) 16 (16.7) 0.7 (0.2–2.8)
>20 21 (87.5) 80 (83.3) 1.0
Marital status
Unmarried 4 (16.7) 10 (10.4) 1.9 (0.5–7.5)
Married 20 (83.3) 86 (89.6) 1.0
Mother’s education level
None/Primary 22 (91.7) 72 (75.0) 3.7 (0.8–16.9)
Secondary 2 (8.3) 24 (25.0) 1.0
Mother’s occupation
Agriculture related 8 (33.3) 25 (26.0) 2.0 (0.5–8.6)
Not agriculture related 16 (66.7) 71 (74.0) 1.0
No. of previous deliveries
None 6 (25.0) 12 (12.5) 2.5 (0.8–8.4)
>1 18 (75.0) 84 (87.5) 1.0
* Odds ratio.
†Confidence interval.
immunization cards. Significantly fewer mothers of neonates
with NNT (20.8%) than control mothers (66.7%) had
received the recommended 2 doses of TT by the time of
delivery (OR = 0.2; CI = 0.1–0.5; p = 0.0001). Mothers of
neonates with NNT also were less likely to have had TT
immunization for previous births (OR = 0.1; CI = 0.02–0.3;
p<0.001). The majority of mothers in both groups had
received prenatal care during the study pregnancy, but this
was not identified as being protective.
All four investigated delivery practices were associated with
NNT (Table 2). Mothers of neonates with NNT were more
likely than control mothers to have delivered outside health
facilities and to have had unskilled birth attendants; 70.8% of
these mothers had unskilled attendants, including traditional
birth attendants (six of 24), friends or relatives (six of 24),
and nursing assistants (five of 24). In contrast, only 31.3% of
controls were delivered by unskilled attendants, including tra-
ditional birth attendants (12 of 96), friends or relatives (nine
of 96), nursing assistants (four of 96), and self (five of 96).
Doctors delivered no neonates with NNT and 3.1% (three of
96) of controls. The rest were delivered by midwives and nurses.
Mothers of neonates with NNT were more likely than con-
trol mothers to have delivered on unclean delivery surfaces
(e.g., mats, sacks, uncovered delivery beds, and uncovered
floors). Certain mothers (three [12.5%] of 24 mothers of chil-
dren with NNT and 36 [37.5%] of 96 controls) reported hav-
ing applied substances into the vagina at onset of labor, a
traditional practice in this region; mothers of neonates with
NNT were less likely than control mothers to have used
intravaginal substances (most frequently herbs) (OR
= 0.2; CI = 0.1–0.8) (Table 3). Bivariate analysis
indicated that the only umbilical cord-care practice
that was associated with NNT was the birth atten-
dant not wearing gloves (OR = 3.8; CI = 1.1–13.1;
p = 0.06) (Table 2).
Multivariate Analysis
The best fitting model for NNT risk factors
explained 71.4% (Nagelkerke R2) of the variation
observed in the outcome variable. Within this model,
the mother receiving 2 doses of TT during the study
pregnancy and a history of receiving TT in previous
pregnancies were significantly protective (p = 0.007)
(Table 4). Receiving only 1 TT dose in study preg-
nancy was not protective and was excluded from the
final model. Delivery on an unclean surface and
primigravidae mothers were associated with increased
risk for NNT. Use of intravaginal substances at
onset of labor was significantly protective, with
mothers of neonates with NNT less likely to have used them
(p = 0.017).
Discussion
This study identified two risk factors for NNT and two
protective factors in the Busoga region of Uganda: unclean
delivery surfaces and primigravidae mothers. Unclean deliv-
ery surfaces were the most likely source of tetanus organisms,
underscoring the importance of using clean delivery surfaces
to prevent NNT. This finding concurs with results of other
studies that identified unclean delivery surfaces as a risk fac-
tor for NNT (8,10). Children born to primigravidae mothers
were at more risk for having NNT than those born to multi-
parous mothers. The association might be confounded by
receipt of TT before pregnancy, which was not captured in
this study.
Intravaginal application of local medicines (most commonly,
herbs) at onset of labor is widely practiced as it is thought to
ease labor by widening the birth canal. This traditional prac-
tice was negatively associated with acquisition of NNT,
implying that it might have had a protective effect. This find-
ing has not been reported previously and requires further clari-
fication. Association might result from reporting bias, as a
mother of a neonate with NNT conceivably might have with-
held information about use of these substances for fear of
being blamed for her child’s illness. Alternatively, applying
such substances immediately after bathing, as is the practice,
might have ensured that clean hands were used, thus decreas-
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ing the risk for contaminating the substances and
the birth canal. This finding is contrary to the
increased risk for NNT observed in other studies of
pregnant women who had predelivery intravaginal
exposure to ghee or coconut oil (8,11). Possibly the
herbs used as intravaginal medications had antibacterial
properties. Further research is required to determine if
these herbs have such medicinal properties.
Absence of the mother receiving 2 doses of TT
vaccination during pregnancy was identified as a risk
factor for NNT, which concurs with findings of pre-
vious studies conducted in Uganda and Nigeria
(6,11,12). The study indicated that <80% of all
mothers in Busoga region had received recom-
mended 2 doses of TT, which suggests that >20%
of children born in the region are still at risk for
having NNT because of low 2-dose TT coverage.
A discrepancy was noted between prenatal care
attendance and maternal TT vaccination. Although
approximately 75% of mothers of neonates with NNT
had prenatal care, only half received >1 dose of TT,
indicating that health-care workers are missing oppor-
tunities to vaccinate pregnant women. This finding has
been documented previously (13–15). This discrep-
ancy might result from mothers receiving prenatal care
only when pregnancy is so far advanced that they can
receive only 1 dose of TT before delivery.
The type of tool used to cut the umbilical cord
was not identified as a risk factor for NNT. This
finding is consistent with a previous study conducted
in Senegal (16) and is probably attributable to the
use of new razor blades and scissors. In addition, no
mother reported having applied any harmful sub-
stance (e.g., cow dung or mud) to the newborn’s
cord wound. This suggests that a positive shift in
cord-care culture has occurred among mothers in
Busoga; certain unhygienic cord practices identified
previously are no longer practiced (6). This change
in cord-care practices might be attributable to wide-
spread health education activities in this region,
especially during recent mass NNT elimination cam-
paigns. It also might result from public awareness of
risk for acquisition of HIV associated with use of
unsterilized instruments.
The findings in this report are subject to at least
five limitations. First, use of unverified maternal TT
vaccination histories might have biased study find-
ings. Second, health education provided during the
NNT elimination campaign might have introduced
reporting bias; however, such bias would be
TABLE 2. Number and percentage of neonates with neonatal tetanus (NNT)
and controls, by delivery practices, cord-care practices, and maternal
tetanus toxoid immunization status — Busoga, Uganda, 2002–2003
Neonates
with NNT Controls Matched
Characteristic No. (%) No. (%) OR* (95% CI†)
Maternal immunization status
at delivery
1 dose of TT§ in study pregnancy
Yes 13 (54.2) 85 (88.5) 0.1 (0.04–0.5¶)
No 11 (45.8) 11 (11.5) 1.0
2 doses of TT** in study pregnancy
Yes 5 (20.8) 64 (66.7) 0.2 (0.1–0.5¶)
No 19 (79.2) 32 (33.3) 1.0
TT in previous pregnancies††
Yes 9 (37.5) 76 (79.2) 0.1 (0.02–0.3¶)
No 15 (62.5) 20 (20.8) 1.0
Delivery practices
Delivery place
Outside health facility 13 (54.2) 26 (27.1) 4.5 (1.4–13.1¶)
Health facility 11 (45.8) 70 (72.9) 1.0
Birth attendant§§
Unskilled 17 (70.8) 30 (31.3) 7.3 (2.1–16.9¶)
Skilled 7 (29.2) 66 (68.8) 1.0
Delivery surface¶¶
Unclean 12 (50.0) 14 (14.6) 6.7 (2.1–21.3¶)
Clean 12 (50.0) 82 (85.4) 1.0
Used intravaginal
substances***
Yes 3 (12.5) 36 (37.5) 0.2 (0.1–0.8¶)
No 21 (87.5) 60 (62.5) 1.0
Cord-care practices
Attendant washed hands
Yes 16 (72.7) 74 (78.7) 1.0
No 6 (27.3) 20 (21.3) 1.5 (0.5–5.0)
Attendant wore gloves
Yes 16 (69.6) 80 (85.1) 1.0
No 7 (30.4) 14 (14.9) 3.8 (1.1–13.1¶)
Cutting tool
New razor blade 14 (63.6) 51 (58.0) 1.0
Scissors 8 (36.4) 37 (42.0) 0.7 (0.2–2.7)
Thread cord tie
Yes 17 (70.8) 71 (74.0) 0.8 (0.3–2.4)
No 7 (29.2) 25 (26.0) 1.0
Cloth cord tie
Yes 4 (16.7) 13 (13.5 1.3 (0.4–4.7)
No 20 (83.3) 83 (86.5) 1.0
Applied substance on cord
Yes 6 (25.0) 33 (34.4) 0.7 (0.3–1.7)
No 18 (75.0) 63 (65.6) 1.0
Prenatal-care attendance
None 6 (25.0) 14 (14.6) 1.8 (0.6–5.3)
At least one visit 18 (75.0) 82 (85.4) 1.0
* Odds ratio.
† Confidence interval.
§ Received >1 tetanus toxoid dose during study pregnancy.
¶ Statistically significant at 0.05 level.
** Received >2 tetanus toxoid doses during study pregnancy.
†† Answered “yes” to question, “Were you ever immunised with TT in previous preg-
nancies or during the recent mass TT immunisation campaign?”
§§ Skilled = doctors, midwives, and nurses; any other = unskilled.
¶¶ Clean = only new plastic sheet or operating theatre; any other = unclean.
*** Answered “yes” to question, “Did you apply any substance into the vagina at onset
of labor?”
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TABLE 3. Percentage of mothers* who used intravaginal
substances at onset of labor, by type of substance used —
Busoga region, Uganda, 2002–2003
Mothers of children Mothers of
Substance with neonatal tetanus controls
Herbs 67% 86%
Burnt snake skin or snail shells 33% 8%
Ghee 0 3%
Vaseline 0 3%
* Mothers of children with neonatal tetanus: n = three; controls: n = 36.
TABLE 4. Adjusted odds ratios (AORs) and 95% confidence
intervals (CIs) for variables retained in the final multivariate
model of risk factors for neonatal tetanus — Busoga region,
Uganda, 2002–2003
Variable         AOR        (95% CI)
Parity
Primigravidae mothers 79.5 (1.8–3472.2*)










Type of cord tie used
Thread 0.1 (0.014–1.1)
Other 1.0
2 doses of TT in study pregnancy**
Yes 0.05 (0.005–0.4*)
No 1.0
1 dose of TT in previous pregnancies††
Yes 0.04 (0.004–0.4*)
No 1.0
* Statistically significant at 0.05 level.
† Clean = only new plastic sheet or operating theatre; any other = unclean.
§ Skilled = doctors, midwives, and nurses; any other = unskilled.
¶ Answered “yes” to question, “Did you apply any substance into the
vagina at onset of labor?”
** Received >2 tetanus toxoid doses during study pregnancy.
†† Answered “yes” to question, “Were you ever immunized with tetanus
toxoid in previous pregnancies?”
nondifferential. Third, recall bias might have occurred because
mothers of neonates with NNT are likely to have a better
recall of circumstances surrounding delivery and cord care than
control mothers. Birth-date matching attempted to equalize
recall difficulties for both mothers of cases and controls.
Fourth, NNT status of participants could not be masked; how-
ever, nonmedical data collectors were employed to minimize
interviewer bias. Finally, only 60% of mothers of neonates
with NNT could be traced, which reduced study sample size.
However, the matched case-control study design with four
controls per case minimized the effect of this limitation.
Conclusion
This study identified two risk factors for NNT: unclean
delivery surfaces and primigravidae mothers. Protective factors
were the mother receiving 2 doses of TT in current pregnancy,
history of TT in a previous pregnancy, and application of intrav-
aginal substances at onset of labor. Cord-care practices were not
NNT risk factors.
On the basis of these findings, the following recommenda-
tions are offered:
• Health-care workers should routinely assess the TT sta-
tus of all female patients of reproductive age and vacci-
nate them according to MOH vaccination guidelines.
• Health-care workers should educate mothers, especially
primigravidae mothers, about the importance of receiv-
ing 2 doses of TT during pregnancy and the need to pur-
chase clean delivery kits.
• MoH and district health teams (DHTs) should collabo-
rate with social marketing organizations to provide preg-
nant women with clean delivery kits (containing gloves,
cord ligatures, blade, plastic delivery sheet, and cotton
wool) at a subsidized fee.
• DHTs should budget for clean delivery kits, which they
should provide at no cost to mothers who cannot afford
to buy.
• The possible prophylactic effects of application of intrav-
aginal substances should be studied further.
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Abstract
Introduction: Brucellosis is a zoonotic disease that is associated with chronic serious sequelae in humans. During 1997–2002,
the reported incidence of human brucellosis in Kyrgyzstan increased nearly twofold, from 20 to 36 per 100,000 popula-
tion. In 2002, the highest incidence of brucellosis was reported in two rural districts of Batkan Oblast: Leylek (106 per
100,000 population) and Kadamjay (80 per 100,000 population). During January–November 2003, trainees from the
Applied Epidemiology Training program in Central Asia conducted a matched, hospital-based, case-control study to identify
risk factors for brucellosis and describe the epidemiology of disease in these two districts.
Methods: Brucellosis cases were defined on the basis of epidemiologic, clinical, and laboratory criteria. During January–
November 2003, a total of 100 persons with confirmed brucellosis were identified in the infectious disease wards of the two
district hospitals; these persons were matched by age and date of admission to 100 controls who were admitted to other hospital
wards for unrelated conditions. Data on socioeconomic and occupational factors and history of exposure to animals and
animal products were collected by using a structured questionnaire. Conditional logistic regression was used to study the
association between exposure variables and brucellosis.
Results: Among the 100 persons with confirmed brucellosis during the study period, 86 (86%) owned farm animals, and
45 (45%) became ill during April–May, the birthing season for farm animals. Multivariate analysis indicated that
brucellosis was associated with exposure to aborted farm animals in the household (odds ratio [OR] = 29.8; 95% confidence
interval [CI] = 4.4–203.4) and consumption of home-made milk products obtained from bazaars or neighbors (OR =
11.4; CI = 1.6–83.9). Knowledge of the mode of brucellosis transmission appeared to be protective against disease transmis-
sion (OR = 0.2; CI = 0.03–0.8).
Discussion: Exposure to aborted home-owned animals and consumption of home-made milk products obtained from bazaars
or neighbors were identified as probable sources of human brucellosis infections in the study districts. This finding suggests that
brucellosis spreads among farm animals in the area and that home-made milk products are not adequately pasteurized.
Conclusion: To reduce the burden of brucellosis in Batken Oblast, veterinary services should be improved, and health
education programs should be increased. Implementing these measures should minimize exposure to farm animals and reduce
the risk for infection from locally produced milk products.
Introduction
Brucellosis is an infectious zoonotic disease that is associ-
ated with chronic debilitating infections in humans and
reproductive failure in domestic animals (1). Although bru-
cellosis occurs worldwide, it is more common in countries
that do not have effective public health and domestic animal
health programs.
Kyrgyzstan (estimated 2003 population: 4,892,808) is an
almost entirely mountainous country in Central Asia that
became independent in 1991 after the disintegration of the
former Soviet Union. An estimated 3,180,000 (65%) persons
live in rural areas. Agriculture accounts for 44% of the country’s
gross domestic product (GDP), and half of the country’s agri-
cultural GDP comes from the livestock subsector (2). Animal
husbandry is the dominant form of agricultural production
in the mountainous regions of Kyrgyzstan.
During the Soviet era, the collective-farm system that
existed in the country accounted for the majority of livestock
production; a high level of state veterinary and sanitary con-
trol was maintained over the livestock population and pro-
32 MMWR April 28, 2006
FIGURE 1. Reported rate* of brucellosis, by year — Leylek and Kadamjay districts,
Batken Oblast, Kyrgyzstan, 1990–2002
















duction. The collapse of the Soviet Union in 1991 led to
social changes and economic hardship that affected all gov-
ernment sectors. The state farming system disappeared, forc-
ing families, especially those in rural areas, to raise farm animals
themselves. These changes in the agricultural sector resulted
in the loss of the state control over the livestock population
and a drastic decline in the quality of veterinary services. In
addition, as a result of deteriorating economic conditions,
Kyrgyzstan was unable to maintain the health infrastructure
inherited from the Soviet era, and the quality and availability
of health services declined, especially in rural areas, where
neither veterinary nor sanitary inspection agencies provide
adequate health services (3,4).
Brucellosis can be transmitted to humans through contact
with animals or their products; it is an occupational hazard to
persons engaged in certain professions (e.g., veterinarians,
slaughterhouse workers, and farmers) (5–7). During 1997–
2002, countrywide incidence of human brucellosis increased
substantially, from 20 to 36 cases per 100,000 population
(Kyrgyz Ministry of Health [MoH], unpublished data, 2003)
(Figure 1); during the same period, the State Veterinary
Department did not report an increase in incidence of brucel-
losis in animals. The greatest increase in incidence during this
5-year period (from six to 68 cases per 100,000 population)
was reported in Batken Oblast, a mountainous area in the
southwestern part of the country. In two districts of this oblast,
Leylek and Kadamjay, incidence of human brucellosis in 2002
was 106 and 81 per 100,000 population, respectively.
Methods
During January–November 2003, in response to a request
from the Kyrgyz MoH, trainees from the Applied Epidemiol-
ogy Training Program in Central Asia conducted a hospital-
based, matched case-control study in Leylek and Kadamjay
districts of Batken Oblast to identify risk factors for brucello-
sis and describe the epidemiology of disease in these districts.
During the study period, 100 persons with confirmed cases
of brucellosis were identified in the infectious disease wards
of the two district hospitals. A case was defined as illness
occurring in a permanent resident of one of the two study
districts who was admitted to either of the two local hospitals
and who received a clinical diagnosis of brucellosis for the
first-time on the basis of the following symptoms: fever
(>99.5°F [>37.5°C]) for >5 days, headache and arthralgias,
and Wright agglutination test dilution >1:100. A control was
defined as a patient with no recent history of brucellosis who
was a permanent resident of one of the two study districts and
who was admitted to the same hospital with a noninfectious
condition during the study period. One control per case was
selected and matched by age (±2 years) and date of admission
(<2 weeks of the brucellosis patient’s date of hospitalization).
The Schlesselman formula for matched case-control design
was used to calculate sample size, with the following param-
eters: the significant level was set at 0.05, the desired power
was 0.8, and the case-to-control ratio was 1:1. To adjust for
confounding, 10% was added to the result. The total number
of pairs needed was 100.
Informed consent was obtained from
all study participants, and person-to-
person interviews were conducted. Data
on socioeconomic and occupational fac-
tors and on exposure to animals and ani-
mal products were collected by using a
structured questionnaire. Clinical and
laboratory data were abstracted from
medical records. A period of 2 months
before date of illness onset for cases and
the same period for corresponding con-
trols was used as the relevant time for
measuring these variables.
Data management and analysis were
performed using Epi Info, version 3.2
(CDC, Atlanta, Georgia). Conditional
logistic regression was used to study the
association between exposure variables
and brucellosis. Potential risk factors
were first assessed in the univariate
analysis. All variables with p values of
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* N = 100.
FIGURE 2. Number of brucellosis cases,* by week of onset — Leilek and Kadamjay
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<0.2 in univariate analysis were selected for multivariate analy-
sis. The stepwise method of model building was used to arrive
at the final statistical model. A p value of <0.05 was defined as
statistically significant.
Results
Of 100 persons with brucellosis who participated in the
study, 69 (69%) became ill during February–May; with the
highest number of illnesses beginning during late April–early
May (Figure 2). The age of ill persons varied (range: 1–75
years; mean: 32 years); 66 were males and 87 were of Kyrgyz
nationality (Table 1). Twelve patients were collective farm
workers; 86 patients reported owning farm animals at home,
including cattle (n = 80), goats (n = 70), dogs (n = 50), and
sheep (n = 49). Among the 86 persons with brucellosis who
had farm animals at home, 70 (81%) cleaned barns, 60 (70%)
assisted in animal delivery, and 22 (26%) slaughtered animals
(Table 1).
Univariate analysis indicated that exposure to aborted ani-
mals (OR = 16.0; CI = 4.5–99.2), assistance in animal deliv-
ery (OR = 5.6; CI = 2.3–16.3), keeping goats at home (OR =
5.2; CI = 2.1–15.2), cleaning animal barns (OR = 3.0;
CI = 1.1–9.2) and being of Kyrgyz nationality (OR = 2.4;
CI = 1.1–5.6) were significantly associated with risk for hav-
ing brucellosis; limited evidence in the univariate analysis sug-
gested that milk products purchased in bazaars or from
neighbors (OR = 1.7; CI = 0.9–3.2) might be associated with
brucellosis.
Multivariate analysis indicated that exposure to aborted home-
owned animals (OR = 29.8; CI = 4.4–203.4), exposure to home-
made milk products purchased in bazaars or from neighbors
(OR = 11.4; CI = 1.6–83.9), and being of Kyrgyz nationality
(OR = 4.8; CI = 1.2–20.3) were independent risk factors for
having brucellosis. Knowledge of the mode of brucellosis trans-
mission was protective (OR = 0.2; CI = 0.03–0.8). Owning a
cow at home was borderline associated with brucellosis (OR = 4.5;
CI = 0.9–23.5) (Table 2).
Discussion
Although brucellosis can occur any time, the majority of
cases occurred during February–May 2003, which is the
birthing season for farm animals. In this season, Brucella can
be excreted in high numbers from infected animals, and the
likelihood of exposure to infected animals increases. Similar
trends have been observed in other countries (7,8).
Humans become infected with Brucellae by coming into
contact with animals or animal products that are contami-
nated with these bacteria. Inadequately heated milk and other
dairy products from infected animals are a primary source of
infection (6,9,10). Person-to-person transmission of Brucella
is extremely rare (1,10). In the two districts studied, exposure
to aborted home-owned animals and eating home-made milk
products purchased in bazaars or from neighbors were inde-
pendent risk factors for having brucellosis. Being of Kyrgyz
nationality was associated with brucellosis; this might be
explained by residual confounding or to other unmeasured
risk. Knowledge of the mode of brucellosis transmission was
protective, which underscores the
importance of health education in pre-
venting of brucellosis. Increased govern-
ment efforts are necessary to improve
education regarding risk factors for bru-
cellosis transmission, especially in rural
areas, where human contact with
domestic animals is widespread.
Brucellosis in Batken Oblast is prob-
ably spread among home-owned ani-
mals, and home-made milk products
obtained from bazaars or neighbors
probably are not adequately pasteur-
ized. The spread of brucellosis in farm
animals might be attributable to the
privatization of collective farms as a
result of the changed political and eco-
nomic situation in the country. Collec-
tive farm animals were distributed
among small private farms; families who
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own these animals might disregard or not be aware of sanitary
and health requirements necessary to prevent transmission of
brucellosis to humans. A probable consequence of privitization
of the animal sector is an increased volume of home-made
animal food products with inadequate sanitary control over
production.
Despite the increase in the number of registered human bru-
cellosis cases, the State Department of Veterinary Services did
not report an increase in the number of brucellosis cases among
animals during the same period. This might reflect the inad-
equacy of veterinary services. In addition, persons who own
their own animals might not seek veterinary service if needed
because of fear that they might lose their source of income.
These findings were discussed by MoH staff and were pre-
sented at conferences attended by staff of international agencies
(e.g., the World Bank and the Swiss Emergency Relief Agency).
Public health and veterinary officials in Kyrgyzstan have deter-
mined that the best approach to reduce the country’s brucello-
sis burden is to focus their resources on improving health
education. Together with the nongovernment organization Rural
Activists for Health, MoH has developed a prevention cam-
paign that targets persons on rural privately owned farms with
livestock. Prevention messages are delivered through the mass
media and focus on use of protection methods (e.g., wearing
protective clothes, especially when assisting in delivery; not per-
mitting children to have contact with animals; and having sick
animals checked by a veterinarian) during contact with animals
and adherence to adequate sanitary standards (e.g., boiling or
pasteurizing) when processing milk and milk products. Brucel-
losis health education brochures and flyers are being distrib-
uted at infectious disease hospitals, local clinics, and health
outposts. In addition, MoH has applied for a grant from the
World Bank to fund brucellosis prevention efforts.
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TABLE 1. Number and percentage of persons with brucellosis,
by selected characteristics — Leylek and Kadamjay districts,
Batken Oblast, Kyrgyzstan, January–November 2003








No formal 4 (4)
Primary 19 (19)
Secondary 61 (61)
Secondary special* 14 (14)
Postsecondary 2 (2)






Relative distribution of cases by type
of exposure to animals (n = 86)
Cleaned barns 70 (81)
Assisted during delivery 60 (70)
Exposed to aborted animals in household 48 (56)
Milked cows 29 (34)
Sheared sheep 27 (31)
Slaughtered animals 22 (26)
* Combines general education with specialized training in a professional field.
TABLE 2. Risk factors for human brucellosis — Leylek and
Kadamjay districts, Batken Oblast, Kyrgyzstan, January–
November 2003
Adjusted
Risk factors  OR* (95% CI†)
Kyrgyz nationality 4.8 (1.2–20.3)
Kept cows 4.5 (0.9–23.5)
Kept goats 1.6 (0.4–6.5)
Cleaned animal barns 3.3 (0.6–17.3)
Sheared animals 0.4 (0.1–2.0)
Slaughtered animals 0.7 (0.1–3.1)
Was exposed to aborted animals
in the household 29.8 (4.4–203.4)
Milked cows 0.5 (0.1–2.6)
Obtained milk products from bazaar
or neighbor 11.4 (1.6–83.9)
Knew how brucellosis is acquired 0.2 (0.03–0.8)
* Odds ratio.
†Confidence interval.
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Abstract
Introduction: During July 9–14, 2004, an outbreak of gastroenteritis occurred among workers at an electronics factory in
Huizhou, Guangdong Province, China; 199 cases were reported. A case-control investigation was initiated to identify the
agent and the mode of transmission.
Methods: Stool samples were collected from 142 workers and food handlers and cultured for enteric pathogens. A question-
naire concerning meals and foods eaten in the factory cafeteria during July 11–13 was administered to 92 ill workers and 100
controls.
Results: Of approximately 2,000 workers who worked during the outbreak, 197 (10%) had illness consistent with the case
definition. Salmonella enteritidis was identified from 44 (31%) of 142 stool samples collected from ill workers. Ill workers
were more likely than controls to have eaten breakfast in the factory cafeteria during July 11–13. Of eight foods served at
breakfast in the factory cafeteria, three were associated with illness: cake, bread (on July 12 only), and congee (i.e., rice
porridge). Stratification of bread and congee exposure by cake consumption indicated that only bread eaten on July 12 was
associated with gastroenteritis. The cake was baked on July 11, and a mixture that included raw eggs was poured on top; the
cake was then stored at room temperature and served for breakfast on 3 consecutive days (July 11–13). The bread was stored
together with the cake on July 11 and 12. No leftover food was tested.
Discussion: The investigation indicated that an outbreak of  S. enterica serotype Enteritidis resulted from consumption of an
unusual food vehicle (i.e., cake) that had been contaminated from a more typical source (i.e., raw eggs). The bread was stored
at room temperature together with cake on which a mixture made from raw eggs had been poured. The bread was probably
contaminated by contact with the cake.
Conclusion: Food handlers should be instructed that intact fresh eggs can harbor S. enteritidis, foods made from eggs must be
cooked, and prepared food must be stored under refrigeration.
Introduction
On July 13, 2004, a local hospital reported to the Huizhou
City Center for Disease Control (CDC) that approximately
70 patients had been admitted that day to the hospital with
gastroenteritis characterized by diarrhea, fever, nausea, and
vomiting. All 70 patients were workers at a local factory that
manufactured electrical products. Investigators from the
Huizhou and Guangdong CDCs visited the hospital and the
factory to identify the agent causing this outbreak. Initial
interviews and review of medical records indicated that for
the majority of patients, onset of gastroenteritis occurred dur-
ing a 2-day period (July 12–13).
Methods
A case of gastroenteritis was defined as illness occurring in
either a factory worker or in a family member who ate a meal at
the factory cafeteria during July 7–16 and who had diarrhea
(two or more liquid stools per day) or fever >99.5ºF (>37.5ºC)
in addition to one of three symptoms: nausea, vomiting, or
abdominal pain. Ill workers were identified from doctors’
reports and from an announcement to workers. Stool samples
were collected from 142 patients (136 workers and six food
handlers) and 24 healthy food handlers. Stool samples were
inoculated to Shigella-Salmonella agar and common agar cul-
ture of enteric bacterial pathogens, including Shigella, Salmonella,
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FIGURE. Number* of cases of gastroenteritis among factory
workers, by time† and date of illness onset — Huizhou City,
Guangdong Province, China, July 9–14, 2004
* N = 92.
†1 = 12:00 a.m.–3:59 a.m.; 2 = 4:00 a.m.–7:59 a.m.; 3 = 8:00 a.m.–11:59 a.m.;
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and Escherichia coli. Slide agglutination tests were used to iden-
tify the suspected bacteria and later the serotype of Salmonella.
As the investigation proceeded, other workers were learned to
have sought treatment at a second local hospital.
A case-control study was conducted to identify the prob-
able vehicle of transmission; 92 ill workers from the two hos-
pitals were selected as a convenience sample, and 100 factory
workers with no symptoms of gastroenteritis were selected as
controls. Controls lived in the same dormitory or were
employed in the same workshop as the ill patients. Ill workers
and controls shared similar demographic characteristics. Dur-
ing July 13–15, the workers were administered a standard
questionnaire that collected demographic information and
asked to state where and what they had eaten at each meal
during July 11–13. Because patients reportedly ate all their
recent meals in the factory cafeteria and drank only boiled
water, the investigation focused on foods served in the cafete-
ria. Respondents were asked to identify which foods they had
eaten for breakfast, lunch, and dinner and to report symp-
toms of gastroenteritis. Frequencies of exposure of ill workers
and controls were compared for all meals. For meals associated
with illness, exposures of different foods served were compared
among patients and controls. Respondents who did not answer
a specific question were not included in the analysis for that
exposure. In addition, a field survey was conducted to identify
whether anything had happened in the factory cafeteria that
was associated with the outbreak, especially in the environment
of the cafeteria and the food preparation process.
Results
Of approximately 2,000 factory workers who worked dur-
ing the 3-day outbreak, 197 (10%) had an illness consistent
with the case definition. An additional two family members
who also ate in the factory cafeteria became ill. Stool speci-
mens from 44 (31%) of 142 ill workers yielded Salmonella
enterica serotype Enteritidis. Of 92 patients interviewed in
the case-control study, the most common clinical symptoms
were diarrhea (80 [87%]), abdominal pain (72 [78%]),
fever (61 [66%]), nausea (26 [28%]), and vomiting (17
[18%]). Onset of illness time was clustered from midnight
July 11 through midnight July 13 (Figure). Patients’ ages
varied (range: 17–50 years; median: 25 years) and reflected the
age distribution of the factory workforce. Between one and
three cases occurred in each of the factory’s 100 dormitories,
each of which housed 15–20 workers.
A comparison analysis indicated that eating breakfast
in the factory cafeteria during July 11–13 was significantly
associated with having gastroenteritis (odds ratio [OR]
range: 3.5–7.5) (Table 1). Eating lunch or dinner on these
days was not associated with illness. Of 92 ill workers, 84
(91%) ate breakfast at least once during July 11–13. Time
intervals between eating breakfast and onset of illness varied
(range: 12–54 hours).
Eight food items were served each day at breakfast: cake,
bread, congee (i.e., rice porridge), steam bread, meat-stuffed
steam patties, fried rice, fried noodles, and boiled noodles.
Eating cake, bread, or congee was associated with illness
(Table 2). These three foods were not served at either lunch or
dinner. The same cake was served on all 3 days and had the
highest OR (OR = 19.0; 95% confidence interval [CI] =
7.4–47.0), whereas bread was associated with illness only on
July 12 (OR = 8.9; CI = 2.9–27.0). On all 3 days, the OR for
congee was lower (OR = 3.6; CI = 2.0–6.6) than that for cake
TABLE 1. Number and percentage of workers exposed who ate
meals at a factory cafeteria, by meal and date — Huizhou,
Guangdong Province, China, July 11–13, 2004
No. of respondents % exposed
Meal/Date Case Control Case Control OR* (95% CI†)
Breakfast
July 11 61 84 72 43 3.5 (1.7–7.0)
July 12 82 98 90 55 7.5 (3.3–17.0)
July 13 44 83 77 48 3.7 (1.6–8.3)
Total 92 100 91 59 7.3 (3.0–18.0)
Lunch
July 11 58 82 64 80 0.4 (0.2–0.9)
July 12 79 93 77 77 1.0 (0.2–2.2)
July 13 28 64 61 67 0.8 (0.3–2.1)
Total 92 100 80 81 1.0 (0.4–2.1)
Dinner
July 11 59 76 68 68 1.0 (0.4–2.1)
July 12 67 87 73 78 0.8 (0.3–1.7)
July 13 18 56 33 66 0.3 (0.01–0.8)
Total 92 100 82 77 1.3 (0.6–2.8)
* Odds ratio.
†Confidence interval.
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At breakfast, the cake and bread were placed on the same
serving platter. After breakfast, the cake and bread were
placed together in an open container, stored at room tem-
perature for another 24 hours, and served for breakfast on
July 12. The bread was completely eaten on July 12, but
leftover cake was served on July 13. Congee was made fresh
each morning by boiling rice in water for 1 hour and served
while still hot. No cake or bread remained for culture. All
eggs used to make the Sela oil were consumed before samples
could be collected.
Salmonella enterica serotype Enteritidis was isolated from
the stool specimens of 10 (33%) of 30 food handlers. Of
the 10 food handlers infected with S. enteritidis, six (60%)
had gastroenteritis (attack rate: 20%). Swabs from the hands
of one food handler also yielded S. enteritidis.
Discussion
The investigation indicated that an outbreak of
S. enterica serotype Enteritidis resulted from consump-
tion of an unusual food vehicle (i.e., cake) that had been
contaminated from a more typical source (i.e., raw eggs).
Sela oil poured on the cake was probably responsible for
the initial contamination, and the cake was the source of
the infection. The high risk for illness from eating both
cake and congee, compared with the absence of risk for
eating congee alone, indicates that the cake was the source of
the infection. The congee might have had a synergistic effect
on the occurrence of illness. The method of preparing congee
(boiling rice in water for 1 hour) would not permit salmo-
nella survival to occur once, let alone in three batches on 3
consecutive days. However, congee has a relatively high pH
(6.4) and could neutralize stomach acid, thus permitting sal-
monellae from cake to reach the small intestine. In addition,
congee could speed gastric emptying, leading to more of the
ingested dose of organisms reaching the small intestine.
S. enteritidis was probably transferred from the cake to the
bread by contact with a common serving platter or utensil, the
hands of a kitchen worker, or flies. Storage for a sufficient time
at room temperature then facilitated multiplication of
S. enteritidis on the bread. Cross contamination without multi-
plication of S. enteritidis probably did not occur because this
would have caused infection on any or all of the 3 days that the
cake was served.
The key event in the outbreak was the preparation of the
Sela oil. After initial contamination from either raw eggs or
another source, both suitable temperature and nutrition were
available for 3 hours for salmonellae to multiply before appli-
cation to the surface of the cake. Once the oil was on the cake,
suitable temperatures for growth of S. enteritidis continued
for another 4 hours. By the time the cake was sold at breakfast
TABLE 2. Number and percentage of workers exposed to salmonellae
who ate breakfast at a factory cafeteria, by type of food eaten and
date — Huizhou, Guangdong Province, China, July 11–13, 2004
No. of respondents % exposed
Food/Date Case Control Case Control OR* (95% CI†)
Cake
July 11 27 32 37 6 8.8 (1.7–45.0)
July 12 69 53 41 8 8.4 (2.5–30.0)
July 13 34 39 59 0 ∞ p<0.01 
Total 92 100 54 6 19.0 (7.4–47.0)
Bread
July 11 27 31 22 10 2.7 (0.5–16.0)
July 12 69 53 42 8 8.9 (2.9–27.0)
July 13 34 39 26 10 3.2 (0.8–14.0)
Total 92 100 37 10 5.3 (2.4–12.0)
Congee
July 11 27 78 31 48 3.7 (1.2–12.0)
July 12 69 67 53 43 2.6 (1.2–5.5)
Total 92 100 62 31 3.6 (2.0–6.6)
Steam bread
July 11–13 92 100 15 10 1.6 (0.78–3.8)
Steam patty
July 11–13 92 100 12 12 1.0 (0.4–2.4)
Fried rice
July 11–13 92 100 20 11 2.0 (0.9–4.4)
Fried noodle
July 11–13 92 100 45 50 0.8 (0.5–1.4)
Boiled noodle
 July 11–13 92 100 13 15 0.9 (0.4–1.9)
* Odds ratio.
†Confidence interval.
(OR = 19.0; CI = 7.4–47.0). The bread and cake were baked
on the evening of July 10 and first served on July 11; they
were then stored together in the same container. The bread
was used up after breakfast on July 12 and replaced with newly
baked bread on July 13. Cake that was left over on July 12
was served again on July 13. Congee was prepared fresh daily
and was not in contact with the bread or cake. Flies were
present in the kitchen, and food handlers seldom washed their
hands while working.
To understand how three different foods could be associ-
ated with a single outbreak, investigators stratified the analy-
sis of these three foods, comparing them alone and in
combination to a single reference exposure (i.e., workers who
had not eaten any of the three foods at any breakfast). This
analysis indicated that cake eaten on any of the 3 days and
bread served on July 12 were associated with illness (Table 3).
Congee alone had no association with illness when eaten with-
out cake but an OR of 53 if eaten with cake.
The cake and bread were baked at midnight July 10. Sela oil
(a mixture prepared from raw eggs, sugar, vinegar, and water)
was poured over the baked cake. On July 10 at midnight, the
Sela oil was heated at approximately 104ºF (40ºC) and stored
at room temperature (77ºF–86ºF [25ºC–30ºC]) for
3 hours before it was poured on the cake. Then the cake was
stored at room temperature for another 4 hours until breakfast.
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TABLE 3. Stratified analysis comparing cake eaten on any
of 3 days to bread eaten on July 12 and congee eaten during
July 11–13, 2004 — Huizhou City, Guangdong Province, China
Cake and bread eaten on July 12
Cake Bread Case Control OR* (95% CI†)
Yes Yes 9 1 37 (4.4–826.0)
Yes No 41 5 34 (11.0–111.0)
No Yes 20 3 28 (6.9–129.0)
No No 22 91 Reference
Cake and congee eaten during July 11–13
Cake Congee Case Control OR* (95% CI†)
Yes Yes 39 2 53 (11.0–343.0)
Yes No 11 4 7.5 (1.9–31.0)
No Yes 18 29 1.7 (0.7–3.8)
No No 24 65 Reference
* Odds ratio.
†Confidence interval.
on July 11, it likely was contaminated. Additional incubation
of the same cake for 24–48 hours is consistent with the con-
tinuing association of illness with the cake for 3 days.
The original contamination of the Sela oil with S. enteritidis
probably came from the raw eggs. Intact shell eggs are known
to become infected with S. enteritidis by vertical transmission
(1–3). S. enteritidis is the only salmonella in chicken embryo
that can be found inside eggs. One infected egg typically con-
tains 10–20 S. enteritidis bacterial cells, but only a few eggs per
1,000 or even 10,000 become infected (3). Infected eggs are
the most likely source of this outbreak. Other less likely pos-
sible sources of infection are a food handler having contami-
nated hands, flies, or other ingredients in the Sela oil.
Transmission of S. enteritidis in association with intact chicken
eggs was first recognized in the United States in 1986 (4,5).
Since then, it has been recognized worldwide (6,7). This is the
first outbreak of S. enteritidis in China that has been attributed
to raw eggs. However, salmonella surveillance and other out-
break reports suggest that S. enteritidis outbreaks occur more
commonly than has been recognized previously. At approxi-
mately the same time as this outbreak, gastroenteritis outbreaks
attributed to S. enteritidis occurred in two nearby cities (Hong
Kong and Guangzhou City, Guangdong Province). Investiga-
tion of the Hong Kong outbreak implicated a mango pudding
made from raw eggs (8). The Guangzhou outbreak was not
investigated. In Hong Kong, salmonella surveillance has indi-
cated that S. enteritidis isolations doubled during 1995–2000
whereas other serotypes remained stable (9). In 10 of China’s
31 provinces that have conducted food surveillance, S. enteriti-
dis is among the top seven salmonella serotypes isolated (10).
In 2000, S. enteritidis was a leading cause of foodborne salmo-
nellosis in the United States (11,12).
The findings in this report are subject to at least four limita-
tions. First, no cake or eggs remained available for testing. Sec-
ond, certain workers could not recall exactly which foods they
had consumed. Third, because of time constraints, ill patients
and controls were selected by convenience and might not be
representative of all persons. Finally, other possible routes of
contamination (e.g., food handlers) could not be excluded.
Conclusion
As a result of this investigation, changes were suggested in the
methods of preparing Sela oil or any other sauce made from
uncooked eggs. Heating the Sela oil to pasteurization tempera-
tures (132.8ºF [56ºC]) for 30 minutes during preparation and
storage of the prepared Sela oil or sauce under refrigeration should
reduce the risk for salmonellosis. Food handlers should be
instructed that intact fresh eggs might harbor S. enteritidis.
Because direct use of raw eggs without cooking might cause sal-
monella contamination of food, food handlers should apply these
guidelines to all foods made from eggs and store foods prepared
with eggs under refrigeration. Researchers and health-care work-
ers should investigate whether such outbreaks occur more
frequently than has been reported previously.
References
1. Gast RK, Beard CW. Detection and enumeration of Salmonella enter-
itidis in fresh and stored eggs laid by experimentally infected hens.
J Food Protect 1992;55:152–6.
2. Humphrey TJ, Baskerville A, Mawer S, Rowe B, Hopper S. Salmonella
enteritidis phage type 4 from the contents of intact eggs: a study
involving naturally infected hens. Epidemiol Infect 1989;403:415–23.
3. Henzler DJ, Kradel DC, Sischo WM. Management and environmen-
tal risk factors for Salmonella enteritidis contamination of eggs. Am J
Vet Res 1998;59:824–9.
4. Angulo FJ, Swerdlow DL. Salmonella enteritidis infections in the United
States. J Am Vet Med Assoc 1998;213:1729–31.
5. Angulo FJ, Swerdlow DL. Epidemiology of human Salmonella enterica
serovar Enteritidis infections in the United States. In: Saeed AM, Gast RK,
Potter ME, Wall PG, eds. Salmonella enterica serovar Enteritidis in
humans and animals. Ames, IA: Iowa State University Press; 1999:33–41.
6. Molbak K, Neimann J. Risk factor for sporadic infection with Salmo-
nella enteritidis, Denmark, 1997–1999. Am J Epidemiol 2002;156:
654–61.
7. Food Safety Authority of Ireland. Report on zoonoses in Ireland 2000
& 2001. Dublin, Ireland: Food Safety Authority of Ireland; 2004.
Available at http://www. http://www.fsai.ie/publications/reports/zoo
noses_report.pdf.
8. Ka-wing A. A major food poisoning outbreak associated with raw eggs.
In: Proceedings of the Third TEPHINET Global Conference [Abstract].
Beijing, China, November 8–12, 2004:177.
9. Yeung ST, Kam KM. Salmonella surveillance in Hong Kong. Public
Health and Epidemiology Bulletin 2001;10:62–7.
10. Wang M, Ran L, Wang Z, Li Z. Study on national active monitoring
for food borne pathogens and antimicrobial resistance in China 2001
[Chinese]. Wei Sheng Yan Jiu 2004;33:49–54.
11. Schroeder CM, Naugle AL. Estimate of illnesses from Salmonella
enteritidis in eggs, United States, 2000. Emerg Infect Dis 2005;11:113–5.
12. Patrick ME, Adcock PM, Gomez TM, et al. Salmonella enteritidis
infections, United States 1985–1999. Emerg Infect Dis 2004;10:1–7.
Vol. 55 / Supplement MMWR 39
Varicella Outbreak Among Primary School Students — Beijing, China, 2004
Huilai Ma,1 R. Fontaine2
1Chinese Field Epidemiology Training Program, Chinese Center for Disease Control and Prevention
2Division of International Health, Coordinating Office for Global Health, CDC
Corresponding author: Huilai Ma, Chinese Field Epidemiology Training Program, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Beijing,
China, 100050. Telephone: 86-10-63022556; Fax: 86-10-83171509; E-mail: huilaima@sohu.com.
Disclosure of relationship: The contributors of this report have disclosed that they have no financial interest, relationship, affiliation, or other
association with any organization that might represent a conflict of interest. In addition, this report does not contain any discussion of unlabeled
use of commercial products or products for investigational use.
Abstract
Introduction: On June 9, 2004, a varicella outbreak was reported in a Beijing primary school affecting approximately 80%
of children in one preschool classroom. An outbreak investigation was initiated to identify factors contributing to the high rate
of transmission and to assess the effectiveness of control measures.
Methods: A varicella case was defined as onset of a generalized, vesicular pruritic rash lasting >4 days in a student at the
school during January 1–June 26, 2004. Parents of all students in the four lowest grades (K–2) were questioned concerning
varicella illness before January 1, 2004. Exposure and vaccination histories of 111 ill students and 120 control students with
no history of varicella were compared.
Results: During January 1–June 26, 2004, of 1,407 students, 138 (9.8%) had varicella; 488 (35%) K–2 students had no
history of varicella before the outbreak. In five classrooms in which attack rates (ARs) were high (>40%), a primary-case
student had remained in school 2 days while ill with a rash. The secondary attack rate (SAR) in these classrooms was 21%,
compared with 1.7% in classrooms in which the first ill student was sent home immediately (risk ratio [RR] = 10; 95%
confidence interval [CI] = 3.7–29.0). A total of 111 (70%) ill students rode the school bus daily, compared with 120 (33%)
control students (odds ratio [OR] =4.9; CI = 2.7–9.0). A total of 73 (33%) ill students had a history of varicella vaccination
before January 1, 2004, compared with 32 (69%) control-students (OR = 0.22; CI = 0.08–0.59).
Conclusion: Students who were not excluded from school on the first day of rash were key contributors to the spread of
varicella in their classrooms. High susceptibility to varicella at school entry indicates that vaccination of susceptible students
might be the only effective measure to control this recurrent problem.
Introduction
Varicella has been a nearly universal disease of childhood.
In temperate climates, nearly 90% of children had varicella
by age 15 years before vaccine became available (1). Before
1995, when vaccine was licensed, an estimated 4 million cases
of varicella occurred each year in the United States; approxi-
mately 100 patients died and 10,000 persons were hospital-
ized annually because of varicella and related complications
(2). Because varicella is not a notifiable disease in China, sta-
tistics concerning hospitalization and death attributable to
varicella are not available. However, since January 1, 2004,
varicella outbreaks have been reported to the public health
emergency reporting system. During January–June 2004, a
total of 64 varicella outbreaks were reported, accounting for
20% of all communicable disease outbreaks reported in China;
58 (91%) varicella outbreaks occurred in schools. Varicella
vaccine has been available commercially since 2003, but China
has no programs to support routine varicella vaccination.
On June 9, the Chinese Center for Disease Control and
Prevention (China CDC) was notified of a varicella outbreak
in a primary school in a suburb of Beijing, affecting approxi-
mately 80% of children in certain classes. Since the school
opened in 1999, varicella outbreaks have disrupted activities
every year, despite a school policy to isolate students with a
rash at home for 7 days. An outbreak investigation was initi-
ated to identify factors contributing to the high rate of trans-
mission and assess the effectiveness of control measures.
Methods
A varicella case was defined as a generalized, vesicular pru-
ritic rash in a school student lasting >4 days with onset during
January 1–June 26, 2004. To identify cases, investigators
reviewed records kept by the school doctor and absentee records
kept by teachers, and teachers and doctors were questioned
concerning rash illness among students. A questionnaire was
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FIGURE 1. Number of varicella cases detected among
children in a primary school, by date of rash onset — Beijing,
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TABLE. Number of varicella cases among primary-school
students, by grade levels — Beijing, China, January 1–June 26, 2004
Age
group No. of No. of
Grade (yrs) students cases AR* (%)
K† 3–5 63 7 11.0
P§ 5–6 194 68 35.0
1st 6–7 213 16 7.5
2nd 7–8 165 32 19.0
3rd 8–9 210 3 1.4
4th 9–10 214 7 3.3
5th 10–11 185 3 1.6
6th 11–12 163 2 1.2
Total 3–12 1,407 138 9.8
* Attack rate.
†Kindergarten.
§Prefirst (between K and first grade).
sent to the parents of any student identified as having a rash
illness to collect information concerning the student’s symp-
toms and the results of any physician consultation. Case
determination was based on the results of all three sources. A
primary case was defined as the first varicella case in a student
with onset of rash to appear in a classroom. A secondary case
was defined as any varicella case in a student with onset of
rash 11–19 days after the onset of a primary case in the same
classroom. A coprimary case was defined as a varicella case in
a student with onset of rash <10 days after occurrence of a
primary case in the same classroom. Secondary attack rates
(SARs) were calculated by dividing the number of secondary
cases by all students with no history of current or previous
varicella minus those with primary and coprimary cases. SARs
for classrooms in which the student with the primary case
had been isolated immediately were compared with SARs for
classrooms in which the student with the primary case had
not been promptly isolated.
A case-control study was conducted; participants included
all 123 students with varicella in grades K–2 and 123 controls
selected randomly from all 365 students in grades K–2 with
no history of current or previous varicella. Self-administered
questionnaires were sent to parents of all 635 students in grades
K–2. Questionnaires requested demographic information, ill-
ness characteristics, varicella vaccination history (including
dates and place of vaccination), previous varicella disease his-
tory, and exposures to varicella. Parents were contacted by tele-
phone to obtain missing information.
Responses were obtained for 111 (90%) of 123 students
with varicella in grades K–2. The exposure histories of these
students were compared with those of 120 control students.
The number of controls selected for each classroom was pro-
portionate to the number of varicella cases that occurred in
the classroom (i.e., frequency matched). In two classrooms
with high attack rates (ARs), an insufficient number of con-
trol students was available, and additional control students
were selected at random from other classes in the same grade.
Results
During January 1–June 26, of 1,407 students, 138 (10%)
had a rash illness consistent with the case definition of vari-
cella. Cases were identified in three ways: 1) the school doctor
examined 77 students and recorded their temperatures; 2) a
doctor in the community examined another 42 students; and
3) 19 students were identified from responses to parent ques-
tionnaires. In addition to a characteristic rash, 64 (46%) stu-
dents had temperature >99.5ºF (<37.5ºC); of these, 36 (56%)
had a temperature >100.4ºF (>38ºC). Four (2.9%) students
had a secondary skin infection. Cases occurred in all eight
grades and in 21 (60%) of 35 classrooms. Higher ARs were
reported among students aged 3–8 years in the four lower
grades (K–2) (Table). Although cases began to appear in Janu-
ary, the outbreak was not evident until mid-April, peaked in
May, and ended with the closing of school on June 30. Dis-
tinct peaks of cases occurred at 15-day intervals during April–
June (Figure 1). Over the course of this outbreak, teachers’
records indicated that 1,090 days of absenteeism resulted from
varicella illness, equivalent to 8 days of school missed per ill
child.
Further analysis was limited to 488 (77%) of 635 K–2 stu-
dents in 15 classrooms who did not have varicella before Janu-
ary 1, 2004. The AR in this group was 25%; analysis of ARs
by classroom identified two distinct groups: 10 classrooms
with ARs <15% and five classrooms with ARs that were sub-
stantially higher (40%–80%). In all classrooms with ARs
>40%, one or more ill students had remained in school >2
days while ill with a rash. These classrooms had new teachers
who were not familiar with the school’s isolation policy. In
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each of these five classrooms, outbreaks began with a student
who was allowed to stay in school for >2 days while having a
vesicular rash. Lax isolation continued during the second gen-
eration of cases in these classroom outbreaks, and tertiary cases
followed (Figure 2).
In the five classrooms in which the student with the
primary case was isolated only after >2 days of rash, the SAR
was 21% (34 of 163) compared with 1.7% (four of 235) in
seven classrooms in which the first student with varicella rash
was isolated immediately (in three classrooms, no cases
occurred) (risk ratio [RR] = 10; 95% confidence interval
[CI] = 3.7–29.0). In three classrooms in which a single stu-
dent with a primary case was not isolated, the SAR was 26%
(29 of 111) (RR = 12; CI = 4.4–34.0) compared with those
FIGURE 2. Number of varicella cases for five primary-school classrooms with attack rate (AR) of >40%, by date of rash onset —
Beijing, China, April 1–June 20, 2004
No. of days students with case
isolated after rash onset
<1 day after rash onset
1–2 days after rash onset
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classes for which cases were isolated immediately. In the two
classrooms with several coprimary cases, the SAR was 9.6%
(five of 52) compared with the classrooms with only isolated
cases (RR = 5.2; CI = 1.5–19). Finally, the five classes in which
a single student with a primary case was not isolated did not
differ from other classrooms regarding crowding, availability
of handwashing, activities involving close personal contact,
or the sharing of items that might act as fomites (e.g., towels,
eating utensils, and cups).
Complete responses were obtained from 111 (90%) stu-
dents with varicella and from 120 (98%) control students.
The case-control study in grades K–2 demonstrated that 78
(70%) ill students used the school bus every day, compared
with 39 (33%) control students (odds ratio [OR] = 4.9; CI =
2.7–9.0); 24 (33%) ill students had a history of varicella vac-
cination before January 1, 2004, compared with 22 (69%)
controls (OR = 0.2; CI = 0.1–0.6). This excludes responses
for 38 ill students and 88 controls whose parents could not
provide the date and place of varicella vaccination or were
otherwise uncertain. Stratification of bus riding and vaccina-
tion by classrooms or grade resulted in adjusted ORs that were
not appreciably different from the crude OR and that indi-
cated no difference in effect between high- and low-incidence
classrooms (classroom-adjusted OR = 4.3; CI = 2.3–8.5 for
bus riding, and 0.24; CI = 0.1–0.7 for vaccination). Parent
questionnaires indicated that only two ill students were known
to have had contact with an ill neighbor before onset of vari-
cella rash.
Discussion
High ARs (40%–80%) in classes from which students with
rash were not sent home immediately are characteristic of trans-
mission among siblings in the home setting and in primary
schools before availability of vaccination (1). In this outbreak,
two factors contributed to high ARs. First, 77% of K–2 stu-
dents had no evidence of protection by natural immunity.
Second, ill students were not isolated promptly, leading to
continuing exposure to varicella for several days and ARs
>40%. The estimated 77% susceptibility for children aged
3–8 years in this school is consistent with the 30% prevalence
of varicella infection in children in Shanghai aged 3–6 years
in 1998 (3).
A factor that could contribute to high susceptibility for
varicella illness is the number of families with only one child
as a result of China’s one-child-per-family policy, which has
been in effect since 1979. By 2001, of approximately 291
million families in China, approximately 130 million (44%)
had only one child, and 102 million (35%) had two children
(4). Preschool children often lack older siblings who could
acquire varicella at school or in the community and subse-
quently infect these more sequestered toddlers and preschoolers
at home. Moreover, child care centers and other concentra-
tions of susceptible infants and toddlers are rare in China.
Under Chinese law, mothers receive 6 months of paid
postmaternity leave to care for their infants. Thereafter, work-
ing parents customarily entrust their children to grandpar-
ents or other older relatives until age 3 years, when the children
are old enough to attend kindergarten. Consequently, the
possibility of exposure of preschool children to natural vari-
cella in the home or community is substantially reduced,
resulting in high prevalence of susceptibility at school entry.
Similar high rates of susceptibility to varicella might be wide-
spread among students in lower grades in China. Vaccinating
susceptible students at school entry might be the most effec-
tive control method. To be effective, vaccination coverage will
need to be >95% because transmission might be sustained in
schools with vaccination coverage of 67%–95%.
Other recommended measures include home isolation of
students with a rash (5,8). In this outbreak, prompt isolation
was associated with lower ARs. However, a high SAR has been
reported in a school despite universal isolation from class at
rash onset; in that investigation, because ill students in all
classrooms were isolated promptly, the effect of isolation could
not be compared with the absence of isolation (9). Isolation is
only a temporary measure that simply delays but does not
prevent varicella illness (1).
To stop this outbreak, investigators recommended adding
vaccination to isolation. However, because the investigation
was conducted near the end of the term, the school could not
implement this recommendation before the school year ended.
Because varicella outbreaks in schools are a common occur-
rence in China, a more effective plan might be to vaccinate
susceptible students when they begin school rather than to
isolate them after an outbreak has begun. Beginning in 2005,
students at this school will be vaccinated at the beginning of
the school year.
In 2003, the Chinese Food and Drug Administration
licensed the Oka-strain varicella vaccine for children aged
>12 months (11). However, varicella vaccine is not included
in national or provincial vaccination programs. A major
obstacle to widespread varicella vaccination in China is the
high cost of this vaccine, which is 10 times more expensive
than rubella vaccine and 75 times more expensive than measles
vaccine. As of 2002, only 131,730 (23%) children in Shang-
hai aged <6 years had received varicella vaccine (10). Another
possible contributing factor is that parents might not be aware
of the availability of vaccine or the need to isolate ill children
at home.
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The findings in this report are subject to at least three limi-
tations. First, information on vaccination and previous his-
tory of varicella disease is subject to recall bias and other
reporting errors on the part of the parents. Vaccination his-
tory in particular suffered from a high nonresponse rate or
responses of “can’t remember” or “unknown.” Accordingly,
only the protective effect is discussed and not vaccine effec-
tiveness or effects on classroom-specific ARs. Second, because
94% of controls and all ill students participated in the study,
selection bias was likely minimal. Finally, why two classrooms
in different grades had multiple coprimary cases is unknown.
Exposure in these classrooms might have led to an earlier, mild
primary case that was missed by the teachers and thus was not
identified. Mild varicella with sparse rashes can occur in vac-
cinated children; these mild infections can be transmitted to
others and have been implicated in transmission in other school
outbreaks (5,7). When cases are missed by school staff and
parents, isolation measures are not taken.
Conclusion
Although no deaths or severe complications occurred in this
outbreak, varicella is a highly contagious disease that can be
fatal (11). In this outbreak, the low level of naturally acquired
immunity was the principal factor underlying the high ARs
recorded. Failure to isolate ill students also contributed to high
ARs in five classrooms. Vaccination was available and protec-
tive, but the decision to vaccinate was left to parents.
Universal vaccination at school entry might be the only
reliable method of controlling varicella. In addition to pre-
venting deaths, vaccination might also reduce hospitalizations
from other varicella-related complications (12). More parents
would be likely to have their children vaccinated if they
understood the effectiveness of vaccine and the consequences
of varicella illness. A stronger policy to encourage varicella
vaccination in schools in China should be developed. Careful
assessment of the cost of vaccine compared with the cost of
disruption of school activities would be valuable in assisting
provinces, educational authorities, and individual schools in
developing a vaccination policy.
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